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IE VITRO STUDIES ON DELAYED HYPERSENSITIVITY 
TO TUBERCULIN
CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW
Delayed-type hypersensitivity, or cell-mediated im­
munity, has recently become the object of intense investiga­
tion both in the laboratory and in the clinic. The apparent 
association of the homograft reaction, certain auto-immune 
diseases, and tumor immunity with specific cell-mediated im­
mune processes has stimulated progress in rescuing this type 
of reaction from the obscurity into which it had fallen.
The main criteria that have been used to dissociate 
delayed-type hypersensitivity from humoral antibody mediated, 
immediate-type hypersensitivity have been that, in the former, 
(1) a characteristic delay in appearance of the local skin 
reaction is observed when the specific sensitizing antigen is 
introduced into the appropriately sensitized host, and (2) 
passive sensitization can be accomplished only with cells of 
lymphoid origin and not with immune serum. More recently, 
the concept of dissociation of cellular and humoral immunity 
has been supported by the observation that certain
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agaüimaglobulinemic patients who are incapable of developing a 
normal humoral antibody response are not compromised in their 
ability to respond normally to delayed-type stimuli (Good and 
Gabrielson, 196^). Further study of the ontogeny of the immune 
response using experimental animal models has resulted in the 
concept that the two types of immunity evolve independently 
during embryonic development (Cooper et al. 1965)- Thus, de­
layed hypersensitivity is thought to be thymus-dependent, 
while humoral antibody is dependent upon the bursa of 
Fabricius in the chicken experimental model, or upon some 
corresponding, but as yet unknown, central lymphoid tissue in 
man (Cooper et al. 1966).
Delayed-type responses to infectious agents, various 
proteins, and innumerable chemical agents appear to be rather 
common in man. However, since the original observations of 
Koch, tuberculin hypersensitivity has served as the model for 
delayed-type reactions to microbial agents. The response to 
proteins of the tubercle bacillus has been studied in detail 
because of its possible role in the pathogenesis of tubercu­
losis. Koch observed that viable or heat killed tubercle 
bacilli innoculated subcutaneously into guinea pigs evoked a 
much more intense inflammatory response in previously in­
fected than in uninfected animals. Subsequently, he found 
that culture filtrates of Mycobacterium tuberculosis were 
also effective in eliciting a delayed-type inflammatory re­
sponse in infected animals.
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Histologically, the delayed-type response is charac­
terized by a massive accumulation of inflammatory cells. 
Initially, granulocytes are abundant about small blood ves­
sels, but by 2h hr the lesions are populated almost exclu­
sively by mononuclear cells (Dienes and Mallory, 1932).
Crowle (1962) described the reaction as a mononuclear cell 
invasion of the effected area with the accumulation of these 
cells around blood vessels to form perivascular islands. In­
filtrating cells may be found in the epidermis, dermis, and 
sub-dermal areolar areas. If invading mononuclear cells in­
volve the epidermis, necrosis ensues, followed by infiltra­
tion of the necrotic area by polymorphonuclear leukocytes.
In a more exhaustive histological study in the guinea pig, 
Spector (1967) described in detail the sequence of cellular 
events in the tuberculin reaction. It was evident from his 
observations that whether the tuberculin reaction is predom­
inantly polymorphonuclear or chiefly mononuclear depends upon 
the time at which the skin test site is examined. The tuber­
culin reaction was clearly different from most inflammatory 
reactions in that it presented a biphasic pattern. A minor 
peak, predominantly polymorphonuclear in nature, occurred at 
3 -̂  hr, probably as a non-specific response to the injection 
of tuberculin. Subsequently, a major peak occurred at 8-12 
hr due to specific sensitization. During this biphasic proc­
ess, the polymorphonuclear leukocytes preceded the mononu­
clear cells in their migration from the vessels. In each
1+
Instance, the granulocytic cells were unimpeded after extra­
vasion and migrated freely throughout the intravascular 
spaces. In contrast, the mononuclear cells appeared to be 
immobilized just beyond the vessel walls to form perivascular 
islands. Ebert et. aJ. (1948) studied the vascular changes in 
the tuberculin-sensitive rabbit using ear chambers. They 
noted that introduction of viable tubercle bacilli into the 
vessels resulted in progressive vascular damage characterized 
by dilation of blood vessels, sticking of leukocytes to the 
vascular endothelium, and diapedesis of leukocytes. Vascular 
damage was followed by hemoconcentration, stasis, and throm­
bosis of small blood vessels with infarction of tissue and 
necrosis. The necrotizing response occurred coincidentally 
with the development of dermal reactivity to tuberculin.
One of the major contributions to the field of de­
layed hypersensitivity was the recognition of the fundamental 
role of the leukocyte. Landsteiner and Chase (194-2) reported 
the passive transfer of delayed-type skin sensitivity to a 
contact sensitizing chemical (picryl chloride) through the 
use of peritoneal exudate leukocytes from sensitive donor 
guinea pigs. In 1945? Chase demonstrated further that de­
layed skin sensitivity to tuberculin was transferable to 
normal guinea pigs by means of leukocytes of peritoneal exu­
dates, spleen, lymph node, or blood from tuberculin-sensitive 
animals. Lawrence (1949) reported the cellular transfer of 
cutaneous hypersensitivity to tuberculin in man by means of
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intact peripheral blood leukocytes from tuberculin-positive 
donors. In further studies (Lawrence, 195^ and 1956), it was 
found that leukocyte extracts were as capable as viable cells 
in the transfer of delayed hypersensitivity in humans. Jeter 
et a2. (195^) reported successful passive transfer of sensi­
tivity to 2,*+,-dinitrochlorobenzene (DNCB) in guinea pigs 
using cells disrupted by sonic vibration. Cummings et al. 
(1956) used similar techniques to accomplish transfer of 
tuberculin sensitivity. Some workers (Chase, 1953 and Eisen, 
1959) have been unsuccessful in confirming these findings 
using the guinea pig as an experimental model. More recently, 
Guthrie e^ a l . (1966) reported that the time after sensitiza­
tion that cells were collected from peritoneal exudates and 
lymph node was critical in the successful transfer of contact 
sensitivity to 1-fluoro-2,^-dinitrobenzene (DNFB) in the 
guinea pig. Moreover, intact peritoneal cells collected 17 
days after sensitization lost their ability to passively 
transfer sensitivity when incubated in balanced salt solution 
at 37 C for 30 min. The resulting incubation supernatant was 
capable of transferring sensitivity. These results demon­
strated the necessity for careful control of procedures and 
handling of peritoneal cells in passive transfer studies using 
the guinea pig model.
Lawrence and Pappenheimer (1957) reported that sensi­
tive human leukocytes, when incubated with specific antigen, 
released a soluble factor (transfer factor) into the
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supernatant fluid which was capable of conferring dermal sen­
sitivity to tuberculin in normal individuals. Guthrie et al. 
(1966) found that when peritoneal exudates from guinea pigs 
sensitized to DNFB were incubated with a conjugate of dinltro- 
phenol and guinea pig serum the supernatant fluid from cells 
collected 13 days after sensitization was capable of trans­
ferring sensitivity to normal animals. However, cells col­
lected at 17 days post-sensitization failed to release transfer 
factor into the supernatant following exposure to antigen. 
Lawrence (1969) has thoroughly studied human transfer factor.
It has been characterized as a dialyzable, low-molecular 
weight (<10,000) moeity that is not antigenic and is not an 
immunoglobulin or a protein. It is insensitive to DNase and 
RNase. Lawrence has suggested that human transfer factor may 
be a polynucleotide or polypeptide molecule which may func­
tion either to convey immunological information and/or act as 
a derepressor of a small number of normal lymphocytes.
Recently, Dupuy ^  a2. (1969, 1970) reported passive 
transfer of delayed hypersensitivity to PPD and to a conjugate 
of dinitrophenol-bovine serum albumin in guinea pigs by re­
peated injection of plasma from sensitized, x-irradiated 
donors into normal recipients. Transfer of sensitivity was 
also achieved by incubating normal spleen cells with plasma 
or serum from sensitized, x-irradiated donors prior to injec­
tion into normal guinea pigs. Chase (1970) was unable to 
confirm these findings and attributed the reactions to humoral
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antibody rather than delayed hypersensitivity. Pabst and 
Dupny (1970) transferred experimental allergic encephalo­
myelitis (EAE) to 25^ of normal recipients which had been in­
jected with plasma from x-irradiated donors with EAE.
The role of the small lymphocyte as the immuno­
competent cell associated with delayed-type reactions has 
been established. Wesslen (1952) passively transferred tu­
berculin hypersensitivity in the guinea pig with viable lymph­
ocytes from the thoracic duct. Waksman et al. (196I) studied 
the histology of tuberculin and contact sensitivity reactions 
in sensitive guinea pigs pre-treated with specific rabbit 
anti-guinea pig lymphocyte serum. This treatment effectively 
lowered the level of circulating lymphocytes and suppressed 
the cutaneous tuberculin reaction. Slavin and Garvin (196̂ +) 
reported successful transfer of sensitivity to dinitrochloro- 
benze and tuberculin in rabbits and guinea pigs with purified 
lymphocyte suspensions, but not with neutrophils. In 1967? 
Turk and Polak reported similar, findings in that local passive 
cutaneous transfer of tuberculin hypersensitivity was con­
sistently obtainable only with purified lymphocyte suspen­
sions prepared from sensitive guinea pig peritoneal exudates. 
Occasional transfer of Arthus-like skin reactivity was ob­
tained with macrophages from the same source. Aran son ejk al. 
(1962) reported that neonatal thymectomy of rats suppressed 
subsequent delayed-type cellular hypersensitivity and the 
number of small, circulating lymphocytes, although plasma
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cell and immunoglob'ulin levels were normal. Cooper ^  al. 
(1965, 1966), in delineating the ontogeny of the immune re­
sponse in the chicken, found that thymectomized and suble- 
thally irradiated newly hatched chicks were incapable of de­
veloping immunological responses associated with delayed-type 
cellular immunity. Morphologically, these animals were de­
pleted of small lymphocytes of the circulation and the white 
pulp type of development in the spleen. Further support for 
the role of the lymphocyte in cellular immune phenomena is 
provided by current in vitro correlates of delayed hypersen­
sitivity (Lawrence, 1968 and 1969) which are dependent on 
interaction of specific antigen with the sensitive lympho­
cyte.
Immunosuppression of delayed hypersensitivity by 
chemical agents has been given much attention recently with 
the advent of tissue and organ transplantation in man 
(Gabrielson and Good, 19 6 7). The role of gluco-corticoids as 
anti-inflammatory and immuno-suppressive agents has been 
clearly established both experimentally and clinically. Long 
and Favour (1950) noted the transient ability of adrenocorti­
cotropic hormone (ACTH) and cortisone to alter delayed-type 
tuberculin skin sensitivity in human patients on steroid 
therapy. Tuberculin reactions were obliterated in 13 of 27 
patients with known sensitivity. The remainder of the pa­
tients showed significant suppression of induration and ery­
thema of the dermal response. In 19515 Vollmer reported the
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suppression of tuberculin skin reactions in 9 known sensi­
tive human volunteers when cortisone was injected along with 
the skin test antigen. Miriok (1951) noted that therapeutic 
doses of cortisone did not diminish the humoral antibody re­
sponse in humans. Neither did it cause more than a transi­
tory lymphopenia. Large doses of cortisone administered to 
patients with lymphatic leukemia resulted in prolonged lym­
phopenia. In studies in experimental animals, Harris and 
Harris (1950) reported that cortisone treatment of BCG- 
infected guinea pigs and rabbits suppressed dermal reactivity 
and systemic shock to Old Tuberculin. Cortisone treatment, 
however, had no effect on Arthus reactivity and humoral anti­
body production in rabbits, nor did it protect guinea pigs 
against anaphylaxis when given prior to shocking challenge 
with antigen.
The suppression of delayed-type skin reactivity may 
not necessarily be specific for an immune mechanism, however, 
since adrenal steroids block inflammatory responses to a va­
riety of non-specific stimuli. In 1951? Osgood and Favour, 
found that treatment of normal guinea pigs with ACTE sup­
pressed the inflammatory response produced by intracutaneous 
injection of oil of turpentine as well as tuberculin skin re­
activity in sensitive animals. ACTH produced marked eosino- 
philia and lymphopenia in these animals. Cell and Hinde 
(1951), in a similar study, analyzed the histological re­
sponse to tuberculin and the response to a non-specific
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irritant (brain phospholipid). In both types of lesions the 
mononuclear component was markedly reduced by cortisone. The 
polymorphonuclear leukocyte component was less effected.
Raffel (1961) suggested that one of the primary difficulties 
in interpreting the effect of immunosuppressive agents in ex­
periments carried out in vivo is that the agent might well 
interfere with the inflammatory response nonspecifically, 
aside from whether or not the animal had responded immuno- 
logically. Germuth (1956) reviewed the role of adrenocortical 
steroids in infection, immunity, and hypersensitivity. He 
stressed that cortisone has a direct effect on the capillary 
tone. That is, decreased capillary permeability results in 
depression of the exudation of fluid and cells from the ves­
sels. Ebert (1952) observed the effect of cortisone on ex­
perimental tuberculosis using the rabbit ear chamber. It was 
noted that cortisone reduced the intensity of the inflamma­
tory process of sensitized animals by maintaining the vascular 
tone and thus reducing diapedesis of leukocytes and damage to 
the vessels involved. Increased susceptibility to infection 
following cortisone therapy appears to be secondary to the 
suppression of the protective inflammatory response. More­
over, one of the most striking effects of cortisone admin­
istration is a reduction in the number of circulating lympho­
cytes and the involution of lymph node tissue, including the 
thymus, spleen, and lymph nodes. Lymphocytopenia is usually 
transient and lymphocyte destruction by cortisone has not been
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demonstrated convincingly. Cummings and Hudgins (1952) found 
that long term administration of cortisone to tuberculin­
sensitive guinea pigs suppressed skin reactivity but did not 
alter the ability of their cells to passively transfer delayed 
hypersensitivity. However, cortisone administration to re­
cipient animals which had received sensitive donor cells 
suppressed the dermal reaction to tuberculin. These results 
suggested that cortisone suppressed the dermal response to 
tuberculin nonspecifically, without altering immune compe­
tency. Jeter and Seebohm (1952) were unable to suppress the 
induction of contact dermal sensitivity to DNCB in guinea 
pigs with high doses of cortisone or ACTH. In further 
studies, Seebohm e_t aH. (195^) were unsuccessful in suppress­
ing the passive transfer of delayed hypersensitivity to DNCB 
by treating donor animals with cortisone or ACTH. However, 
recipient animals treated with ACTH, but not those given 
cortisone, displayed depressed dermal reactions following 
passive sensitization. Shewell and Long.(1956) studied the 
effect of cortisone acetate on body weight, gamma globulin 
levels, and production of circulating anti-toxin in various 
species. They noted that man, monkey, and the guinea pig 
are relatively resistant to cortisone as compared to rabbits, 
rats, and mice. In 1957, Long suggested that the effect of 
adrenal steroids varied greatly in different species based 
on their innate potential to synthesize various steroid de­
rivatives endogenously. For example, the major steroids
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elaborated by the adrenal cortex of the rat, mouse, and rab­
bit are corticosterones, but these species produce very little 
cortisone or hydrocortisone. Thus, exogeneous administration 
of these agents leads to dramatic effects on their immune 
capability. In contrast, in those species (man, monkey and 
guinea pigs) in which cortisone is normally manufactured there 
is a relatively small effect following exogenous administra­
tion of the agents. Furness (1959) studied the effect of 
hydrocortisone succinate on the macrophages of various species 
of animals in vitro. Guinea pig macrophages were found to be 
10 to 100 times more resistant to the effect of steroid, as 
measured by morphological changes and their ability to adhere 
to glass, than were those from the rat and mouse. Cortisone 
and its analogues have been shown to inhibit thymus-dependent 
experimental autoimmune disease. Development of experimental 
allergic encephalomyelitis in the guinea pig was suppressed 
by cortisone in studies by Moyer ejt al. (1950) and Ferraro 
and Roizin (1.953)- The latter workers noted that the disease 
developed after treatment was discontinued. Cortisone admin­
istration has also been reported to suppress adjuvant arth­
ritis in rats (Pearson and Wood, 1959)-
Adrenal steroids have been used most successfully in 
suppression of transplantation imm'unity, Dillingham et al.
(1951) and Morgan (1951) observed independently that treat­
ment with cortisone prolonged skin allograft survival signif­
icantly in rabbits. In guinea pigs. Sparrow (1953) reported
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that cortisone acetate was effective in donhling the survival 
of skin allografts when large doses were injected subcutane­
ous ly. In a similar study, Weisman et al. (1951) reported 
that intramuscular administration of high doses of cortisone 
or ACTH was ineffective in prolonging homologous skin grafts 
in guinea pigs. Thus, it appears that cortisone is most ef­
fective in prolonging homografts when given in depot form at 
the time of grafting. The role of cortisone in thymus- 
dependent immunity was supported by the studies of Udall 
(1955)- He observed that treatment of newborn rats with 
cortisone significantly reduced the number of thymocytes in 
the thymus and suggested that cortisone may prevent the mat­
uration of the precursors of lymphocytes in the thymus.
Results of in vitro studies on the influence of ad­
renal steroids on delayed hypersensitivity are confusing. 
Leahy and Morgan (1952) reported that cortisone inhibited the 
cytotoxic action of PPD on macrophages from splenic explants 
of tuberculous guinea pigs. However, preincubation of the 
cells for 2k hr with a high concentration of cortisone (100 
mcg/ml) prior to the addition of PPD was found to be essen­
tial. Glasgow e_t al. (1958) demonstrated a protective effect 
of cortisone against specific antigenic damage in cultures of 
spleen from guinea pigs sensitive to mumps viral antigen. In 
contrast, Holden e_t al. (1953) were unable to detect any pro­
tective effect of cortisone on damage by PPD to splenic ex­
piants from sensitive guinea pigs, mice, and rabbits or buffy
1>+
coats from tuberculin-sensitive rabbits. However, cortisone 
was added in small concentrations (0 . 5  mcg/ml) simultaneously 
with antigen in these studies. Heilman (19^5)5 using a dif­
ferent in vitro method, was also unable to demonstrate corti­
sone protection against the cytotoxic effects of tuberculin 
on sensitive cells. Johnson and Sherago (1964) reported that 
intraperitoneal cortisone treatment of tuberculin-sensitive 
guinea pigs significantly decreased in vitro sensitivity of 
peripheral blood leukocytes as measured by inhibition of mi­
gration of buffy coat leukocytes by tuberculin when the number 
of mononuclear cells was significantly lowered.
The specific mechanism by which adrenal steroids sup­
press delayed hypersensitivity at the cellular level remains 
controversial. There is, however, some indirect evidence, 
aside from the immunologically non-specific pharmacologic ef­
fects of cortisone on cell mediated immunity, that these 
agents probably act directly on the macrophage and the lymph­
ocyte. Cortisone has been shown to inhibit the release of 
lysosomal enzymes from isolated rabbit liver lysosomal gran­
ules by ultraviolet irradiation (Weissman and Dingle, I9 6 1) 
and by endotoxin (Weissman and Thomas, 1962). The authors 
postulated that the mechanism of action of cortisone on the 
macrophage was through stabilization of the lysosomal mem­
branes. In support of this concept, Lurie et al. (1952) noted 
that macrophages from cortisone-treated rabbits readily en­
gulfed bacteria, but that the organisms tended to accumulate
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in the phagocytic cells and were not as well digested as in 
control animals. In a similar study, Hsu (1969) examined the 
effect of in vitro infection with virulent tubercle bacilli 
on macrophages from cortisone-treated and untreated guinea 
pigs. Wo difference was noted in the rates of bacillary mul­
tiplication within these two populations of macrophages. 
Cytologic studies, however, revealed that the intracellular 
infection was significantly more toxic to the host cells de­
rived from the cortisone-treated animals. One of the most 
striking effects of cortisone and ACTH administration is a re­
duction in the number of circulating lymphocytes and involu­
tion of lymphoid tissue, including the thymus, spleen, and 
lymph nodes (Dougherty, 1952). However, lysis of lympho­
cytes due to exposure to cortisone has never been demonstrated 
convincingly (Germuth, 1956). In a histological study, Craig
(1952) found that cortisone treatment of rabbits prior to 
antigen administration suppressed stimulation and mitosis of 
lymph node lymphocytes. Hinz et al. (1970) observed that 
specific antigenic stimulation of lymphocytes from tuberculin- 
sensitive patients correlated quantitatively with the tuber­
culin skin reactivity of the cell donor but failed to corre­
late with levels of serum antibody. Moreover, one tuberculin- 
positive patient given high doses of prednisone as a thera­
peutic regimen displayed significantly decreased stimulation 
of his lymphocytes by PPD, as measured by indirect assays for 
blast transformation by incorporation of initiated thymidine.
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Dermal reactivity to tuberculin remained positive in this pa­
tient during the period of in vitro suppression. Upon reduc­
tion of steroid dosage and subsequent cessation of therapy 
his lymphocyte response in vitro returned to pre-treatment 
levels. These findings suggest that the specific role of 
cortisone on the lymphocyte may be in part due to inhibition 
of lymphocyte proliferation.
The recent development of in vitro models for study­
ing delayed hypersensitivity at the cellular level has pro­
vided reproducible, quantitative methods which may eventually 
shed light on the molecular basis of this phenomenon. Early 
attempts to develop in vitro systems were plagued by a lack 
of reproducibility. However, Rich and Lewis (1932) developed 
an in vitro system which clearly demonstrated both the inhi­
bition of migration and the cytotoxic effects of tuberculin 
on mononuclear cells from splenic explants of tuberculous 
guinea pigs. Their findings stimulated a great deal of fur­
ther in vitro work by various workers using similar methods. 
This subject has been reviewed extensively by Heilman (1963)*
More recently, several in vitro methods have been 
described which appear to correlate with some phase of 
delayed-type cellular immunity in vivo. All of these in 
vitro correlates of delayed hypersensitivity are mediated by 
a group of soluble factors generated by antigen-activated 
lymphocytes from sensitive animals (Lawrence, 1968). The in­
teraction between the immunocompetent lymphocyte and specific
17
antigen can result in a variety of biological phenomena, the 
form of which depends on the environment in which the cellular 
response to antigen is assayed. Four such in vitro phenomena 
include: (1) production and transfer of delayed hypersensi­
tivity by means of viable lymphoid cells or their subcellular 
fractions containing transfer factor (Lawrence, 1969), (2) 
transformation of sensitized lymphocytes by specific antigen 
(Robbins, 196^; Oppenheim, 1968; and Dutton, 1967), (3) cyto- 
pathic or cytotoxic effects of sensitized lymphocytes on tar­
get cell populations, the surfaces which bear the specific 
antigen (Perlmann and Holm, 1969 and Rosenau, 1968), or target 
cell destruction not dependent on histocompatibility differ­
ences (Ruddle and Waksman, 1967, 1968; and Waksman, 1968), 
and (*+) inhibition of macrophage migration (David, 1968 and 
Bloom and Bennett, 1968). These non-antibody mediators of 
cellular immunity generated by lymphocyte activation have 
recently been categorized as "Lymphokines" by Dumonde et al. 
(1969).
One of the most useful and thoroughly studied in 
vitro models of cellular immunity in recent years has been 
the inhibition of macrophage migration from capillary tubes. 
George and Vaughan (1962) developed an in vitro method which 
consisted of culturing peritoneal exudate cells from guinea 
pigs exhibiting delayed hypersensitivity in capillary tubes. 
Migration of the sensitive cells out of the tubes in fan­
like patterns onto glass coverslips enclosed in Mackaness
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chambers was inhibited when specific antigen, incorporated 
in tissue culture medium, was added to the chambers. Migra­
tion of normal cells in the presence of antigen and sensi­
tive peritoneal cells without antigen was not inhibited.
Cells from animals sensitized to egg albumin in complete 
Freund's adjuvant (CFA) were inhibited in vitro only when de­
layed skin reactions were demonstrable in the animals. David 
et al. (1964a) established that the specific inhibition of 
macrophage migration correlated with delayed-type hypersensi­
tivity and not humoral antibody production. Peritoneal exu­
date cells from guinea pigs with delayed-type hypersensitiv­
ity to tuberculin, and either ovalbumin or diphtheria toxoid 
as antigen-antibody complexes in CFA, were specifically in­
hibited in vitro only by the corresponding antigen used for 
sensitization. Moreover, cells obtained from animals pro­
ducing only precipitating antibody without delayed hypersensi­
tivity or normal cells incubated with serum from tuberculin- 
sensitive animals were not inhibited in vitro. Inhibition of 
macrophage migration occurred when heat-inactivated serum was 
incorporated into the tissue culture medium, suggesting that 
the system was not complement dependent. These workers were 
unable to demonstrate passive sensitization of normal cells 
incubated in serum containing a high titer of humoral anti­
body to various protein antigens. Bloom and Bennett (1966) 
also reported that peritoneal cells from guinea pigs that had 
been immunized with protein antigens adsorbed to alumina gel
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(in order to produce high titers of hemaggIntirating anti­
body but no detectable delayed hypersensitivity) were not in­
hibited ,in vitro by the inducing antigen. Further evidence 
has established the correlation of this in vitro model with 
delayed cellular immunity. David and Paterson (1965) re­
ported that peritoneal cells obtained from guinea pigs with 
experimental allergic encephalomyelitis (EAE) were inhibited 
specifically ,in vitro by antigens prepared from nervous tis­
sue. In a similar study, Rauch et al. (1969) found that per­
itoneal macrophages obtained from guinea pigs 7 days following 
treatment with an EAE-inducing dose of purified basic protein 
from bovine spinal cord in CFA were inhibited by the same 
antigen in vitro. Al-Askari e_t al. (1965) used the George 
and Vaughan in vitro method to detect homograft sensitivity. 
They found that peritoneal cells from inbred mice with homo- 
graft sensitivity were inhibited ,in vitro when mixed with 
viable peritoneal cells from the strain of mice that had 
donated the sensitizing skin homografts. In vitro inhibi­
tion of migration was not demonstrable, however, when cells 
from one inbred strain of mice were mixed with cells from a 
genetically different strain.
Benacerraf and Gel (1959) demonstrated that the car­
rier protein determined the specificity of delayed-type re­
activity in vivo in animals immunized with hapten-protein 
conjugates, while the immediate-type response was predomi­
nantly hapten-specific. David et al. (I964h) confirmed the
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importance of delayed-type carrier protein specificity using 
the in vitro capillary tube system. Peritoneal cells from 
guinea pigs immunized with DNP-protein conjugates were spe­
cifically inhibited in vitro only by the homologous antigen 
and not by hapten conjugated to a heterologous carrier pro­
tein. In contrast, serum antibodies from the same animals 
reacted with the hapten regardless of the carrier protein.
Lipsmeyer and Kantor (1969) demonstrated in vitro 
desensitization of peritoneal cells from guinea pigs with de­
layed hypersensitivity to hapten-protein conjugates by pre­
exposing the cells to the sensitizing antigen prior to in 
vitro assay for inhibition of macrophage migration. When 
cells from animals sensitized to multiple antigens (i.e., bo­
vine gamma globulin, PPD, and picryl-guinea pig albumin) were 
pre-exposed to the latter antigen, there was a loss of re­
sponsiveness to all three antigenic specificities in vitro.
Recent immunochemical studies utilizing highly de­
fined antigens have revealed the unique stereo-specificity 
required for elicitation of delayed or immediate hypersensi­
tivity. Antigens which consisted of DNP conjugated to oligo­
peptides of L-lysine were found to be immunogenic for guinea 
pigs if the hapten oligopeptide had 7 or more lysyl residues 
(Yaron and Schlossman, 1966). In vivo delayed-type skin re­
sponses were demonstrable only to <=KDNP-oligopeptide conju­
gates consisting of 7 or more lysyl residues, while those 
containing 3 to 6 lysyl residues (non-immunogenic) could
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readily elicit Immediate-type reactions in vivo, but not de­
layed type responses (Schlossman et al. 1966). David (1968) 
confirmed these i_n vivo findings using the in vitro macro­
phage migration inhibition technique. Peritoneal cellg from 
guinea pigs immunized with c<DNP oligolysines with an average 
of 18 residues were inhibited in vltro in the presence of 
^DNP oligopeptides with 8 or more lysyl residues, but were not 
inhibited with those composed of 3, or 6 lysines. These 
studies demonstrated that only DNP oligopeptides, which are 
immunogenic and can elicit delayed hypersensitivity in vivo, 
are capable of specifically inhibiting cell migration in 
vitro.
Several attempts have been made by various workers to 
compare the time required for induction of delayed-type skin 
reactivity with, that required for development of in vitro 
cellular sensitivity. Leu and Patnode (1968) reported that 
delayed-type skin reactivity in guinea pigs rendered sensi­
tive to PPD was uniformly positive at 1 week, while signifi­
cant in vitro sensitivity could not be detected until 3 weeks 
post-sensitization. Ferraresi et (1969), in a similar 
study in guinea pigs sensitized with diphtheria toxoid (DT) 
and human gamma globulin (,HGG) incorporated in CFA, found 
that skin reactivity developed earlier and more rapidly than 
did in vitro sensitivity. Ricci et al. (1969) reported that 
in vitro sensitivity of peritoneal cells from tuberculin- 
sensitive guinea pigs was, in general, not significant until
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3 weeks following sensitization. David (1964a) reported 
that, although inhibition of migration could not be directly 
correlated with the diameter of PPD skin reactions, there was 
a close parallelism. He suggested that skin reactivity may 
not necessarily parallel the sensitivity of other tissues.
In contrast, Dumonde (1967) stated that, in unpublished work, 
in vitro sensitivity of guinea pig peritoneal cells could be 
detected on the sixth day after immunization and correlated 
with the occurrence of delayed skin reactivity, but not with 
the size of the skin reaction. Recently, Marcus (1970) re­
ported that, under carefully controlled experimental condi­
tions, macrophage inhibition was demonstrable simultaneously 
with the onset of tuberculin skin sensitivity. The condi­
tions that appeared to be crucial in this experiment included: 
(1) intradermal injection of inbred guinea pigs in multiple 
sites with minimal doses of sensitizing antigen (i.e., 12.5 
to 25 meg. of heat killed mycobacteria), (2) use of homologous 
guinea pig serum, carefully selected to be non-toxic for 
cells, and (3 ) avoid chilling of peritoneal exudate cells. 
However, it was not apparent from this study whether any one, 
or all, of these factors were prerequisite to the early in­
duction and/or detection of in vitro sensitivity.
The observation that small numbers of sensitive cells 
can effect large numbers of normal cells in eliciting delayed- 
type hypersensitivity reactions has been well established in 
vivo (Najarian and Feldman, 196I, 1963, and McCluskey et al..
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1963). David et aJ. (I96^c) noted that when as few as 2.5^ 
sensitive peritoneal cells were mixed with normal peritoneal 
cells inhibition of the whole cell population by antigen 
could be detected in vitro. Furthermore, they found that the 
sensitive cells must be viable to exert their effect on nor­
mal cells. In further studies (David, 1966 and 196?), at­
tempts were made to determine the cell type (lymphocyte or 
macrophage) responsible for conferring the effect on normal 
cells. When cell preparations containing 95^ lymph node or 
spleen lymphocytes obtained from guinea pigs sensitive to PPD 
or to a hapten-protein conjugate were mixed with normal peri­
toneal macrophages, the resulting population was inhibited 
from migrating by specific antigen. Since the sensitive 
lymph node cells alone or normal peritoneal cells alone were 
not inhibited by antigen in vitro, it was concluded that two 
different cell types were required for the inhibition of mi­
gration. Bloom and Bennett (1966) described similar experi­
ments using lymphocytes and macrophages separated from peri­
toneal exudates. They reported that migration of normal peri­
toneal exudate cells was inhibited by PPD only when a few 
sensitive peritoneal lymphocytes were present in the mixture. 
Moreover, peritoneal macrophages from sensitive exudqtes 
rendered free of lymphocytes were no longer inhibited from mi­
grating by specific antigen. It was concluded that, in this 
system, the lymphocyte possessed the immunological informa­
tion, while the macrophage was simply the Indicator cell which
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migrated. The fact that so few lymphocytes could affect the 
migration of normal macrophages led to a search for a soluble 
material elaborated by lymphocytes upon interaction with spe­
cific antigen. Bloom and Bennett (1966), using purified pop­
ulations of sensitized peritoneal lymphocytes, and David
(1967)5 utilizing sensitized lymph node lymphocytes, reported 
that incubation of these cells in the presence of specific 
antigen resulted in the elaboration of a soluble factor into 
the surrounding medium. When the cell-free supernatants were 
used as the medium for normal peritoneal cells, inhibition of 
migration occurred. Bartfeld and Kelly (1968) reported sim­
ilar findings using peripheral blood lymphocytes from 
tuberculin-sensitive guinea pigs. Therefore, it became clear 
that sensitized lymphocytes, upon interaction with antigen, 
elaborate a soluble migration inhibitory factor (MIF) which 
can inhibit migration of normal macrophages.
The mechanism of action of MIF remains unclear. Early 
in vitro observations (Rich and Lewis, 1932, and Kapral and 
Stinebring, 1958) suggested that tuberculin was both inhibi­
tory and cytotoxic for macrophages from sensitized animals. 
Recently, Galvin et a2. (1969) observed microscopically a 
specific aggregation of sensitized lymphocytes with normal 
macrophages in the presence of antigen. However, it should be 
emphasized that, in contrast to other in vitro systems, the 
capillary tube method is performed under short term tissue 
culture conditions (24-^8 hr incubation) with relatively low.
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non-cytotoxlc concentrations of antigens. Bloom and Bennett
(1966) noted that the macrophages remained viable even though 
their migration was inhibited. Bloom and Bennett (1968) sug­
gested two possible mechanisms for MIF-mediated macrophage 
inhibition. Either MIF has specificity and requires combina­
tion with specific antigen, or it acts as a non-specific 
pharmacologic agent on the macrophage. Using an indirect ap­
proach, Bennett and Bloom (1967) reported that MIF-containing 
supernatants, resulting from short term exposure (i.e., 
"pulsing") of sensitive lymphocytes to PPD followed by washing 
and overnight incubation of the same cells in antigen-free 
medium, resulted in some inhibition of migration when they 
were added to normal macrophages in vitro. However, if excess 
antigen was added to the same supernatants, the degree of in­
hibition was markedly enhanced. The p.uthors concluded that 
the potentiation of MIF by added antigen suggested that MIF 
may have specificity, although the possibility existed that 
the potentiation was due to the non-specific cytotoxic ef­
fects of PPD on the macrophage. Svejcar e^ al. (1968) con­
firmed these findings using the rabbit as an experimental 
animal. Amos and Lachmann (1970) reported that the presence 
of antigen was required for MIF to inhibit macrophage migra­
tion. These workers found that MIF-containing supernatants 
from lymphoid cells cultured with an insoluble antigen- 
polymer complex (PPD coupled to polyaminostyrene), and subse­
quently cleared of antigen by centrifugation, were largely
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devoid of Inhibitory activity. Activity was restored by add­
ing antigen back during incubation with normal macrophages.
MIF thus appeared to be antigen-specific and, to this extent, 
antibody-like. The authors postulated that MIF acts as a 
cytophilic factor for macrophages which are then held together 
by antigen. In contrast, Dumonde ejt al. (1969) separated spe­
cific protein antigen, gamma globulin and MIF from cell-free 
incubation supernatants by means of gel filtration (Sephadex 
G-100) and salt precipitation. MIF activity still remained, 
in the absence of antigen, gamma globulin, and immune com­
plexes. The authors concluded that antigen was not necessary 
for the inhibitory effect of MIF on the macrophage once it is 
produced by sensitive lymphocyte-antigen interaction. Con- 
canavalin A has been reported to suppress delayed hypersensi­
tivity to tuberculin in vivo (Leon and Schwartz, 1969). In 
in vi tro studies, (Schwartz e_t al. , 1970) concanavalin A was 
found to induce the non-specific release of MIF from non- 
immune lymphoid cells obtained from guinea pigs, rabbits, and 
man. These results support the concept that MIF is not spe­
cific and that antigen is not required for MIF-mediated 
macrophage inhibition once MIF has' been released.by sensitive 
lymphocyte-specific antigen interaction.
Numerous attempts have been made to better character­
ize the mechanism and kinetics of MIF synthesis, as well as 
its physical, chemical, and macromolecular properties.
Studies using metabolic inhibitors of protein synthesis
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indicated that puromycin (David e_b al., 196H-d) and raitomycin-C 
(Bloom and Bennett, 1966) prevent inhibition of migration by 
antigen. It appeared, therefore, that MIF production was as­
sociated with active protein synthesis. Bennett and Bloom
(1967) reported that MIF could be detected in supernatants as 
early as 6 hr after exposure of sensitized lymphocytes to 
antigen. In addition, MIF was elaborated continuously for 5 
days in long term lymphocyte cultures. In attempts to deter­
mine the effect of proteolytic enzymes on the in vitro system, 
David ^  al. (19641) found that when sensitive peritoneal exu­
date cells were incubated with trypsin or chymotrypsin they 
were no longer inhibited by antigen. Sensitive cells re­
covered from the effects of trypsinization, however, if they 
were cultured in suspension for 24 hr prior to in vitro assay. 
Similar treatment of sensitive cells with RNase and DNase had 
no effect. In a more definitive study, Pochyly (1967) found 
that trypsinization of sensitive lymph node lymphocytes 
blocked their ability, when mixed with normal exudate cells, 
to elicit in vitro inhibition of macrophage migration. Incu­
bation of normal peritoneal exudates with trypsin had no ef­
fect on the reaction when untreated sensitive lymphocytes and 
antigen were added to the system. Bloom and Bennett (1968a) 
confirmed these results using purified guinea pig peritoneal 
and lymph node lymphocytes. These results suggested that 
trypsinization may have removed a specific receptor site on 
the sensitized lymphocyte which was resynthesized when trypsin
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activity was blocked. However, Remold and David (1970) re­
cently found that chymotrypsin and neuraminidase treatment 
abolished inhibitory activity of MIF-containing cell free 
supernatants. These results suggested that soluble MIF was 
susceptible to enzymatic degradation.
In attempts to fractionate the active component(s) 
of inhibitory supernatants by gel filtration on Sephadex G- 
200 (David, 1968; Bloom and Bennett, 1968; and Dumonde ejt ad. 
(1969), inhibitory activity has been consistently associated 
with the third peak obtained, i.e. that containing albumin. 
These results suggest that MIF has a molecular weight of ap­
proximately 7 0,0 0 0. MIF is non-dialyzable (Bloom and 
Bennett, 1966), heat-stable at 56 C for 30 min (David, 1966), 
cryolabile at 4 C and -20 0 (Bartfeld and Kelly, 1968), and 
lyophilizable and stable at -70 0 after lyophilization 
(Bennett and Bloom, 1967).
A role of a cytophilic antibody in delayed hypersen­
sitivity has been postulated (Karush and Eisen, 1962). Al­
though most workers have failed to demonstrate any correla­
tion between MIF-mediated macrophage migration inhibition and 
humoral antibody, there is currently some convincing evidence 
that there may exist a separate macrophage Inhibition mechan­
ism which is dependent on an antibody cytophilic for macro­
phages. Boyden (196’+) demonstrated an antibody in guinea pig 
anti-sheep erythrocyte sera which was selectively bound to 
peritoneal macrophages, but not to lymphocytes or granulocytes.
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This cytophilic antibody was shown to confer to macrophages 
the ability to bind sheep red cells on their surface (rosette 
formation). Production of cytophilic antibody was induced 
only by incorporation of the antigen in complete Freund’s ad­
juvant (CFA) and not with incomplete Freund's adjuvant, ^hich 
indirectly suggested a correlation with delayed-type hypersen­
sitivity. Amos e_t ad. (1967) reported that conventional Y-2 
guinea pig antibody cytophilic for peritoneal macrophages 
mediated inhibition of normal macrophage migration in the 
presence of specific antigen. Bloom and Bennett (1966) also 
reported that normal macrophages could be inhibited in vitro 
by antigen and specific antiserum from guinea pigs immunized 
with bovine serum albumin, ovalbumin, or CFA. In the tuber­
culin-sensitive animals, repeated PPD skin tests were per­
formed prior to the collection of immune serum until strong 
Arthus reactions were obtained. Krejci et al. (1 9 6 8) found 
that serum collected from hypersensitive guinea pigs previ­
ously challenged intravenously with antigen conferred in 
vitro sensitivity on normal macrophages. Recently, Spitler 
and Fudenberg (1970) reported that intravenous injection of 
immune serum from guinea pigs'sensitized with CFA into normal 
recipients conferred MIF-mediated sensitivity on their peri­
toneal exudates assayed in vitro 3 days later. Benacerraf
(1 9 6 8), using the "rosette" technique of Boyden and guinea 
pig alveolar cells as a source of macrophages, identified the 
guinea pig cytophilic antibody by zone electrophoresis and
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other criteria as Y-2, and not Y-1 immunoglobulin. Pepsin di­
gestion destroyed its ability to bind to macrophages. There­
fore, the cytophilic binding site was apparently associated 
with the Pc fragment of the molecule. However, the author 
concluded that cytophilic antibodies of this type, added pas­
sively to macrophages, did not elicit inhibition of macro­
phage migration in the presence of added antigen. Nelson and 
Mildenhall (1968) found no correlation between cytophilic 
antibody titer and delayed-type dermal response to sheep 
erythrocytes or human serum albumin at 1-3 weeks following 
sensitization. Heise et al. (1968) clearly demonstrated in 
vitro inhibition of migration of alveolar macrophages ob­
tained from BCG-sensitized guinea pigs to be due to a cyto­
philic antibody which was not MIF. The cytophilic antibody 
activity was transferable passively to normal alveolar mac­
rophages by heat elution from sensitive alveolar and peri­
toneal macrophages or by immune serum. Further studies re­
vealed that MIF-mediated activity was demonstrable in super­
natants when sensitive lymph node lymphocytes from the same 
animals were incubated with antigen. Similar incubation of 
alveolar macrophages from sensitive animals resulted in no 
activity in most experiments. Finally, the cytophilic anti­
body was characterized by gel filtration, salt precipitation, 
and immunochemical methods as an IgG immunoglobulin, probably 
of the Y-2 type, which was distinct from MIF.
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Thor (1967, 1968) reported that delayed-type immune 
competency was transferable to normal cells in vitro via RNA 
extracts of human lymph nodes from tuberculin-sensitive and 
histoplasmin-sensitive individuals or patients with active 
tuberculosis using the macrophage inhibition technique. When 
the cell-free extracts containing RNA from sensitive donors 
were incubated with normal human lymphoid cells, in vitro in­
hibition of migration occurred in the presence of specific 
antigen. The active fraction was inactivated by treatment 
with RNase, but not by trypsin or DNase. Jureziz ejt al.
(1968) reported transfer of MIF-like activity with RNA ex­
tracts by the same methods using the guinea pig as the experi­
mental animal. The RNA extracts used in these experiments 
were not transfer factor, but were similar to the material 
found by Fishman (196I), Adler et al, (1966), and Cohen (1967) 
to convert non-immune cells into antibody-forming cells in 
experimental animals. Thor and Schlossman (1969) reported 
that specific antigen-induced MIF-activity was detected in 
culture supernatants from normal lymphoid cells passively 
treated with RNA extracts from guinea pigs sensitive to DNP- 
oligolysine antigens,
At present, a considerable amount of confusion exists 
as to the relationship, if any, between MIF and the various 
other in vitro correlates of delayed hypersensitivity.
Bennett and Bloom (1967) reported that "blast-cell" transfor­
mation is not a prerequisite to MIF production, since the
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latter Is elaborated Into culture supernatants prior to the 
time that transformation occurs. This experiment did not, 
however, disprove the possibility that MIF-producing lympho­
cytes are the same sensitive cells that subsequently undergo 
transformation. Spitler and Lawrence (1969) compared the in 
vitro biologic activity of substances produced during stimu­
lation of human peripheral blood lymphocytes by specific anti­
gen. They found that the degree of MIF activity produced was 
proportional to the degree of lymphocyte transformation. 
Moreover, MIF-containing supernatants enhanced transformation 
of normal lymphocytes. Maclaurin (1969) noted that phyto­
hemagglutinin (PHA) induced the formation of intercellular 
cytoplasmic bridges between macrophage monolayers in tissue 
culture. The same effect was induced by stimulating sensi­
tive macrophages with tuberculin. Fireman et aJL. (196?) re­
ported similar inducement of transformation when dialyzable 
transfer factor was added to normal human lymphocytes in the 
presence of antigen in vitro. Paque ^  ad. (1969) reported 
that when non-sensitive human lymphocytes were incubated with 
specific antigen and lymphoid cell lysates obtained from 
histoplasmin, coccidiodin, or tuberculin skin test positive 
human donors, the non-sensitive cells were sensitized and 
released a substance which specifically inhibited the migra­
tion of guinea pig macrophages. Dumonde et al. (1969) dem­
onstrated that cell free supernatants resulting from sensi­
tive lymphocyte-antigen interaction were capable of eliciting
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delayed-type dermal responses in vivo, as well as in vitro 
activities including MIF, mitogenic factor, and a factor cyto­
toxic for target cells. Bennett and Bloom (1968a and 1968b) 
reported that intradermal injection into normal guinea pigs 
of MIF-containing cell-free supernatants produced a cellular 
response typical of delayed hypersensitivity, although the 
time required for development was accelerated (maximal at 
8-12 hr and disappeared by 30 hr). Krejci et al. (1969) con­
firmed these results. Ward and David (1969) described a 
leukotactic factor in supernatants from sensitive lymphocytes 
incubated with antigen which was not dissociable from MIF ac­
tivity by physical methods.
The immunologic specificity of acquired cellular re­
sistance to infection has not been established (Mackaness, 
1968). In recent in vitro studies, however, Mackaness (1969) 
presented evidence that lymphoid cells from mice infected 
with Listeria monocvtogenes confer immunelogically specific 
protection upon normal animals, as determined by activation 
of peritoneal macrophages. Mooney and Waksman (1970) demon­
strated the activation of rabbit macrophages by supernatants 
of antigen-stimulated, sensitive lymphocytes which contained 
MIF activity. They suggested that a similar specific acti­
vation may be responsible for cell-mediated immunity.
The objectives of this research were fourfold; (1) 
Develop a modified in vitro method for studying delayed hy­
persensitivity to tuberculin in the guinea pig; (2) Study and
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correlate the time required for induction of delayed-type skin 
reactivity and in vitro macrophage migration inhibition; (3) 
Examine the sensitivity of guinea pig alveolar macrophages to 
tuberculin in vitro; and (h) Study the effect of cortisone ad­
ministration on the induction and expression of tuberculin 





Male, albino, Hartley strain guinea pigs (Cavla 
norcellus ), weighing approximately 300-*+00 g, were used In 
these experiments. All animals were obtained from the same 
commercial source^ and were maintained on a diet of commer­
cial pellets which was supplemented weekly with fresh cabbage 
leaves. The animals were housed no more than 5 per cage and 
were held for observation at least 2 weeks prior to experi­
mental use.
Organisms and Cultural Conditions 
Mycobacterium tuberculosis, (strain H37Ra) was grown 
on a modified Proskauer and Beck synthetic medium (Youmans 
and Karlson, 19^7) for ^ to 6 weeks at 37 C In Roux flasks 
containing 150 ml of medium. Whole cells were separated from 
the culture medium by suction filtration through a Buchner 
funnel containing Whatman No. 1 filter paper. The moist cells
 ̂Camm Research Institute, Incorporated, H-l̂- Black 
Oak Ridge Road, Wayne, New Jersey.
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2were pooled, washed three times in pyrogen-free 0.85^ NaCl,' 
and killed by heating in a hot water bath at 60 C for 1 hr 
(Redmond and Bowman, 1955)* The heat-killed organisms were 
dried in a hot air oven at 110 C for 1 hr, ground to a fine 
powder in a sterile mortar, and stored at ^ 0 in a sealed 
Petri dish. A preparation of heat-killed Mycobacterium tu­
berculosis . strain H37Rv, grown on Proskauer and Beck medium 
and prepared in a similar manner, was kindly supplied through 
the courtesy of Dr. B. W. Janieki, Veterans Administration 
Hospital, Washington, B.C. The latter antigen was used in 
most of the experiments.
Preparation of Sensitizing Antigens
Sensitizing antigens were prepared by homogenizing a 
mixture of heat-killed mycobacterial cells (strain H37Rv),
10 ml Freund's incomplete adjuvant,^ and 5 ml pyrogen-free 
0.85^ NaCl for H- min on a Sorval Omnimixer.^ The H3/Ra anti­
gen preparation contained 5 mg organisms per ml. Another 
group of sensitizing antigens was prepared with the H37Rv 
strain to yield final concentrations of 0.5, 1.0, 2.$\ 5*0, 
and 10 mg organisms per ml. All of the antigens were freshly 
prepared just prior to sensitization of experimental animals.
pCutter Laboratories, Berkeley, California.
^Difco Laboratories, Detroit, Michigan.
Ivan Sorvall, Inc., Norwalk, Connecticut.
37
Sensitization of Guinea Pigs 
Preliminary Sensitization Studies
In order to determine the optimal method to render 
normal guinea pigs hypersensitive to tuberculin, the following 
procedures were evaluated:
1) Subcutaneous Injection In the nuchal area (nape of 
the neck) of 1 ml (5 mg) of H3?Rv antigen.
2) Intramuscular Injection In the groin of 1 ml (5 
mg) of H37Rv antigen.
3) Intramuscular Injection In the groin and subcu­
taneous Injection In the nuchal area with 1 ml/slte (10 mg 
total) of H37Rv antigen.
Sensitization of Animals for 
In Vitro Studies
To obtain a source of sensitive peritoneal exudate 
cells for in vitro macrophage migration studies, normal ani­
mals were Injected subcutaneously In the nuchal area with 1 ml 
of antigen containing 0.5? 1.0, 2.$\ 5*0, or 10.0 mg of heat- 
killed H37Rv organisms.
Sensitization of Animals for Alveolar 
Macrophage Studies
For most in vitro studies of guinea pig alveolar mac­
rophages, animals were sensitized subcutaneously with 5 mg 
H37Rv antigen as described previously. In addition, a group 
of normal guinea pigs was sensitized according to the method 
of Helse e_t al. (1968). Each animal was Injected
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subcutaneously on the dorsal side with a total of 2.4 mg H3?Rv 
antigen by injecting 0.1 ml (0.4 mg) into 6 different sites.
A third method of sensitization involved the intravenous in­
jection of 0.75 or 1.25 mg of heat-killed H37Rv cells in 
pyrogen-free 0.85^ NaCl to which'3 drops of Tween 80^ had been 
added. In a similar experiment, 2 groups of normal guinea 
pigs were injected either intravenously or intracardially with 
0.5 ml (2.5 mg) of H37Rv cells in pyrogen-free 0.85^ NaCl to 
which 3 drops of Tween 80 had been added. A final group of 
animals was injected intrapleurally into the lung with 0.5 mg 
of H37Rv antigen.
Skin Tests
In preliminary studies, sensitized animals were skin 
tested by the intradermal injection of 0.1 ml (5 meg) Purified 
Protein Derivative, PPD, (Merck Sharp and Dohme)̂  diluted in 
the commercial phosphate buffer supplied by the manufacturer. 
In order to avoid non-specific skin reactivity attributed to 
certain batches of the commercial diluent, PPD was subse­
quently diluted in pyrogen-free 0.85% NaCl. PPD was injected 
into the shaved dorsal skin. The injection sites were varied 
in experiments where multiple skin tests were performed on 
the same animal. The diameter of induration and the presence
^Atlas Chemical Industries, Inc., Wilmington,
Delaware.
^Merck Sharp and Dohme, West Point, Pennsylvania.
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of erythema and/or central necrosis were recorded 2̂- hr after 
injection of PPD. Reactions measuring 1$ mm or more of in­
duration were considered to be significant as an index of 
sensitization.
Histological Studies
Skin test sites were obtained by biopsy from normal 
and tuberculin-sensitive guinea pigs 2h hr after injection of 
the skin test antigen. Tissues were placed in an automatic 
tissue processor (Auto-technicon)? for dehydration through 70, 
80, 9 0, 95? and 100# ethanol, clearing in absolute ethanol- 
xylol in a ratio of 1:1, followed by pure xylol, and imbed­
ding in paraffin using standard Tissue-Tek^ imbedding equip­
ment. Tissue sections were cut on a rotary microtome at a 
thickness of 7 microns. Sections were stained with Harris's 
hematoxylin-eosin stain according to the methods outlined in 
the Manual of Histologic and Special Staining Techniques 
(I960).
Collection of Guinea Pig Peritoneal 
Exudate Cells
Peritoneal exudate cells were obtained from normal and 
tuberculin-sensitive guinea pigs 72 hr after intraperitoneal 
injection of 30 ml sterile light paraffin oil^ (viscosity
^The Technicon Company, Chauncey, Hew York.
O
Lab-Tek Instruments Company, Westmont, Illinois.
%isher Scientific Company, Fair lawn. New Jersey.
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125/135). In certain experiments animals were Injected In 
the same manner with 2-5^ Starch Gel^^ In pyrogen-free 0.85^
NaCl. Food was withheld from all animals 2k hr prior to cell 
collection. The animals were sacrificed hy Intracardlal 
bleeding, followed by Injection of an air embolus and/or cer­
vical dislocation. Exudate cells were collected by aseptic 
technique. A ventral midline Incision was made In the peri­
toneal wall and the viscera and peritoneal cavities were 
washed with approximately 120 ml Hanks balanced salt solution 
(HESS) containing 0.4 units heparln/ml (sodium heparin Llpo- 
heparln).11 The peritoneal washings were centrifuged at 
150 x g for 15 min and the supernates were discarded. The 
packed cells were resuspended and pooled In 5 ml Eagles mini­
mal essential medium (EMEM) with Earls balanced salt solu­
tion^ ̂ containing 15^ normal homologous commercial guinea pig 
serum^^ (EMEM-8). Normal guinea pig serum was decomplemented 
by heating at 56 0 for 30 min prior to Incorporation Into 
EMEM. The cell suspension was centrifuged at 64 x g (920 rpm) 
for 5 min In 13 ml graduated screwcap centrifuge tubes and the 
packed cell volumes were recorded. Total leukocyte counts
^®Mann Research Laboratories, Division of Beeton, 
Dickinson and Company, New York, New York.
"̂'Rlker Laboratories, Northrldge, California.
12Hyland Laboratories, Los Angeles, California. 
Colorado Serum Company, Denver, Colorado.
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were made using the Unopette^^ diluting method, followed by 
standard hemocytometer counts. The cells were resuspended in 
EiyEM-S to a final concentration of approximately 1.5-1-8 x 10*̂  
cells/ml. For most experiments a 10^ packed cell volume, 
which resulted from centrifugation at 6^ x g for 5 min, was 
diluted in ^0% EMEM-S to give a final cell concentration of 
approximately 1.5-1.8 x 1 o'̂ cells/ml. Cell suspensions were 
kept in ice throughout the experiment. Differential counts 
were performed on Wright'Srstained dried smears of the cell 
suspensions. Peritoneal exudates consisted mainly of mono- 
nuclear cells with approximately 10-30# lymphocytes, 70-90# 
macrophages, and 0-10# polymorphonuclear leukocytes.
Collection of Guinea Pig 
Alveolar Macrophages
For the purpose of obtaining sufficient quantities of 
alveolar macrophages relatively free of erythrocyte contami­
nation, two methods were evaluated.
In Situ Method
The in situ method of Maxwell et al. (1964) was used 
in preliminary studies. The animals were sacrificed by intra- 
cardial bleeding and cervical dislocation. The thoracic 
cavity was opened and the trachea was dissected away from sur­
rounding connective tissue. A hemostat was attached to the 
tracheal wall and the trachea was transected above this point.
I^Becton, Dickinson Company, Rutherford, New Jersey.
i+2
The tapered end of a small glass tube which was connected to 
the tip of a 3-way stopcock (Luer lock)^^ by means of poly­
ethylene tubing was Inserted into the lumen of the trachea.
Two 25 ml Luer lock syringes were attached to the stopcock 
and supported by a ring stand and clamps. The upper reser­
voir syringe was filled with HESS (non-heparinized). After 
adjusting the stopcock valve, 10-15 ml of HESS was carefully 
injected into the lungs. The stopcock valve was then adjusted 
to allow the cell suspension to enter the receiving syringe. 
The above procedure was repeated, using 5-10 ml volumes, until 
a total of 120 ml of washing fluid was obtained.
Method of Myrvik
For most experiments, guinea pig lung macrophages 
were collected according to a method modified from that of 
Myrvik et al. (1961). Prior to sacrifice by intracardial 
bleeding, the animals were injected intraperitoneally with 
0 . 5  ml epinephrine^^ (adrenalin chloride, 1:1,000) and 5 ml 
(125 mg) of Nembutal”''̂ (pentobarbital, sodium) in 0.85% NaCl. 
The thoracic cavity was opened and the trachea dissected free . 
and transected as described previously. The anterior portion 
of the trachea was clamped off by means of a hemostat and the 
trachea-lungs-heart complex was removed as a unit. The heart
^^Eecton, Dickinson Company, Rutherford, New Jersey.
16,
Jersey.
Parke, Davis and Company, Detroit, Michigan. 
^7j. T. Eaker Chemical Company, Phillipsburg, New
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was carefully dissected away from the lungs. In order to 
eliminate residual blood contamination, the lungs-trachea com­
plex was rinsed repeatedly in O.Q5% NaCl and blotted with 
sterile gauze pads. Sterile HBSS (10 ml) was carefully in­
jected into the lungs via the trachea by means of a syringe 
and needle. The tapered end of a glass tube connected to a 
3 inch polyethylene tube was inserted into the lumen of the 
trachea and the washing fluid was drained into a sterile tube 
by gravity, with gentle massage of the lungs. The lungs were 
perfused repeatedly in the same manner until 80-120 ml of 
washing fluid had been collected.
The macrophage-containing washing fluids obtained by 
either method of collection were centrifuged at 6̂- x g (920 
rpm) for 15 min. The cell pellets were resuspended in 5-10 ml
HBSp and centrifuged at 64 x g for 5 min. The cell pellets
were then resuspended in 5 ml EMEM-S and centrifuged at 64 x g 
for 5 min prior to adjustment of cell concentrations to ap­
proximately 1 X 10? cells/ml of EMEM-S. Differential leuko­
cyte counts were performed on Wright's stained dried smears. 
Lung washings consistently contained 95-98% alveolar macro­
phages with an occasional lymphocyte or polymorphonuclear 
leukocyte. The total cell yields obtained by the in situ 
method varied from none to 7 x 10^ cell/lung, while the modi­
fied Myrvik method resulted in dependable yields of 1.5-3 x
1 o'̂ cells/lung.
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Preparation of Purified 
Lymphocyte Suspensions
Attempts were made to prepare purified lymphocyte sus­
pensions from guinea pig peritoneal exudates by the method of 
Bloom and Bennett (1966). Washed, oil-induced peritoneal ex­
udate cells from normal or sensitive animals were pooled in 
EMEM-S to a final concentration of approximately 5 x 10^ 
cells/ml. The cell suspensions were pipetted, in 5 mT 
amounts, into standard, 100 mm plastic disposable Petri dishes 
and incubated at 37 C for 45 min to allow adsorption of the 
macrophages to the bottom surface of the plates. After in­
cubation, the plates were agitated gently to remove the unat­
tached cells. The supernates which contained lymphocytes and 
unadsorbed macrophages were aspirated from each Petri dish and 
pooled prior to centrifugation at 1 50 x g for 5 min. The cell 
pellets were resuspended in EMEM-S, distributed again in ster­
ile Petri dishes in 5 ml amounts, and the adsorption procedure 
was repeated. The resulting adsorbed cell suspension con­
sisted of approximately 85^ lymphocytes and the cell recovery 
constituted l4^ of the original volume.
Passive Transfer Experiments 
Passive transfer of tuberculin hypersensitivity was 
attempted with viable and sonic-disrupted cells. Donor cells 
were obtained from pooled, oil-induced peritoneal exudates ob­
tained from animals sensitized intramuscularly with 5 mg 
or H3/Ra antigen. One-half of each pooled cell suspension was
^5
sonicated in a Branson Bonifier (Model S-75)^^ at a peak set­
ting of 8 (1>+ amp) for 3 min. The cell suspension was kept 
cool in ice during the sonication process to prevent over­
heating. All donor guinea pigs were skin tested with 5 meg 
PPD 2k hr prior to sacrifice. Normal guinea pigs that had not 
been previously skin tested were used as recipients. The re­
cipient animals were injected intraperitoneally with 2.3-2.6 
X 10^ cells or the equivalent of sonic lysate. The recipient 
animals were skin tested with 5 meg PPD 3 and 6 days after 
transfer. In a preliminary experiment cells were obtained 
from donors with relatively weak tuberculin skin reactivity 
(i.e., mean induration of 12 mm). This group had been.sensi­
tized with 5 mg H37RV antigen 10-12 months previously. In a 
second experiment 20 donor animals were divided into 2 groups 
of 10 animals each, based on the type of sensitizing antigen 
used. Group 1— sensitized with H37Rv antigen, strong skin 
reactivity (mean induration, 22 mm); and Group 2--sensitized 
with H37Ra antigen, weak skin reactivity (mean induration,
15 mm). All donor animals were sensitized 5 weeks prior to 
cell collection. In addition, cells and sonic lysates from 
normal guinea pigs served as controls.
In Vitro Macrophage Migration Method 
A method modified from that of George and Vaughan 
(1962) was used as a means of assaying delayed
18Heat Systems Company, Melville, New York.
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hypersensitivity to tuberculin in vitro. The method described 
by George and Vaughan, and used extensively by several other 
workers, Involves the use of Mackaness Chambers for incubat­
ing cell-containing capillary tubes in the presence of antigen
incorporated in tissue culture medium. In the present stud-
19les, a short-style, Leighton-type tissue culture tube  ̂was
substituted for the Mackaness Chamber (Leu and Patnode, 1968).
20Small capillary tubes, 1-3-1-5 mm in diameter and 75 mm 
long, were filled with the cell suspension, sealed at one end 
with sterile plasticene and centrifuged at 64 x g for 5 min. 
The tubes were then cut at the cell-fluid interface with a 
diamond point glass etcher. The portion of the tube contain­
ing the cells was attached to a glass coverslip by means of a
21small amount of silicone lubricant and placed in a short- 
style, Leighton-type tissue culture tube. Peritoneal or alve­
olar cells from each donor animal, whether normal or sensi­
tive, were prepared so that at least 2 Leighton tubes were 
filled with 1.0 ml of EMEM-S without antigen and at least 2 
tubes were filled with EMEM-S to which appropriate concentra­
tions of PPD had been added. After the medium was added, 
each Leighton tube was stoppered tightly with a siliconized 
rubber stopper, incubated at 37 C, and examined at 18 hr. 
Quantitation was performed by projecting the image of the
I^Bellco Glass, Incorporated, Vineland, New Jersey.
20Scientific Products Company, Dallas, Texas.
21 Dow Corning Company, Midland, Michigan.
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area of migration onto drawing paper by means of a Bausch and 
Lomb microprojector.22 The outer edge of the projected image 
was outlined and the area of migration was measured by means 
of a planimeter.23 The following formula was used to express 
the degree of migration:
Mean Area of Migration
Per Cent Migration _  With Antigen ^ ^QQ
With Antigen Mean Area of Migration
Without Antigen
In preliminary experiments, inhibition of migration 
was determined qualitatively by examining the preparations 
with an inverted light microscope.
Two types of PPD were used for in vitro experiments.
pitSeveral batches of a commercial PPD preparation, which was
also used as a skin test antigen, were evaluated. The prep­
arations were supplied as ^0 meg tablets which contained 
purified cresols (0.06 mg) as a preservative. A second PPD 
preparation, free of preservatives and excipients, was kindly- 
supplied in powder form by Dr. M. W. Fisher, Parke Davis 
Company, Research Division, Detroit, Michigan.
Effect of Incubation Time on 
Macro-phage Migration
Studies were performed to determine the optimal in­
cubation time for recording macrophage migration in the in
22Bausch and Lomb, Incorporated, Rochester, New York.
21-̂ Keuffel and Esser Company, New York, New York.
2^Merck Sharp and Dohme, West Point, Pennsylvania.
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vitro system. Two types of experiments were conducted,. In 
the first experiment, capillary tubes containing oil-induced 
peritoneal exudate cells from a sensitive donor were prepared 
by the techniques described previously. To one-half of the 
Leighton tubes was added 1.0 ml EMEM-S (without antigen).
One ml of EMEM-S containing 5 meg PPD was added to each of the 
remaining tubes. The tubes were then incubated at 37 C and 
the area of migration of cells in each tube was recorded after 
4, 8, 1 8, and 24 hr. In the second experiment, peritoneal 
exudate cells obtained from 4 sensitive animals were pooled 
and 4 identical sets of capillary tubes were prepared. One- 
half of the Leighton tubes in each set were filled with medium 
containing 5 meg PPD/ml, while the remaining tubes served as 
controls. All of the tubes were incubated at 37 C and one set 
was examined at each time interval (4, 8, l8, and 24 hr). By 
this procedure it was possible to avoid sloughing of cells 
from the coverslips due to repeated handling of the tubes.
Endnoint Titration of PPD 
It became evident early in this work that commercial 
PPD preparations were highly toxic for normal cells. These 
findings necessitated the development of an endpoint titra­
tion method as a standardization procedure for each lot of 
commercial PPD used. This was accomplished by determining 
the degree of migration of both normal and tuberculin- 
sensitive cells in the presence of various concentrations of 
each lot of PPD. The endpoint was defined as that
9̂
concentration of PPD that would significantly inhibit sensi­
tive cell migration but would be least inhibitory for normal 
cell migration.
Studies on the Time Required for Induction 
of Tuberculin Hypersensitivity 
in Guinea Pigs
Studies were performed on the development of the de­
layed response to mycobacterial antigen and attempts were 
made to correlate in vitro cellular sensitivity with tubercu­
lin skin reactivity. In a preliminary experiment, two groups 
of normal guinea pigs were sensitized intramuscularly with 
5 mg H37Rv antigen. Representative animals from one group 
were sacrificed, without skin testing, at weekly intervals 
for 5 weeks and their peritoneal cells were tested in vitro 
for sensitivity to 10 mcg/ml of PPD. Animals in the second 
group were skin tested with 5 meg PPD at weekly intervals for 
the same time period. A second experiment was performed in 
the same manner in which normal animals were sensitized by 
subcutaneous injection of 5 mg H3?Rv antigen. Peritoneal 
cells from representative animals were tested in vitro at 
weekly intervals for 5 weeks for sensitivity to 5 meg PPD.
The effect of different dosages of sensitizing antigen on the 
induction of sensitivity was studied in similar experiments. 
Groups of normal animals were sensitized with 0.5, 1.0, 5-0, 
or 10.0 mg of H37Rv antigen and in vitro assays were performed 
on peritoneal cells from representative members of each group 
of animals at weekly intervals for 3 weeks. A portion of the
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animals from each group was reserved for repeated weekly skin 
testing.
In Vitro Studies on the Sensitivity of 
Alveolar Macrophages
In preliminary studies alveolar cells obtained from 
PPD-sensitive animals (sensitized subcutaneously with 5 mg 
H3?Rv antigen) were collected and studied in vitro for their 
sensitivity to PPD by the methods described previously.
In a subsequent experiment, the cellular sensitivity 
of alveolar and peritoneal cells from the same sensitive 
donors were compared. In order to accomplish this, 2 normal 
and 2 sensitive (sensitized subcutaneously with 5 mg H37Rv 
antigen) guinea pigs were injected with sterile paraffin oil 
by methods described previously. The animals were sacrificed 
72 hr later and both the alveolar and peritoneal cells were 
collected and tested individually in vitro using 5 or 15 meg 
PPD by the methods described previously.
Intravenous and Intracardial Challenge 
of Sensitive Guinea Pigs with 
Mycobacterial Antigens
In order to determine the effect of intravenous and 
intracardial challenge with PPD on the in vitro sensitivity 
of alveolar macrophages obtained from tuberculin-sensitive 
guinea pigs the following experiment was performed: 
Tuberculin-sensitive and normal guinea pigs were injected 
either intravenously or intracardially with 25 meg or 1 mg 
PPD (without preservatives, obtained from National Institutes
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of Health, Bethesda, Maryland) in pyrogen-free 0.8^% NaCl. 
Twenty-four hours later the animals were sacrificed and their 
alveolar cells were collected and studied for sensitivity to 
PPD in vitro.
Transfer of MIF-Mediated Sensitivity 
In Vitro By Mixing Sensitive 
and Normal Cells
In order to transfer MIF-mediated sensitivity in 
vitro, peritoneal cell suspensions from tuberculin-sensitive 
and nonsensitized donors were mixed in various proportions 
according to the method described by David et al. (I96^c).
By this method, 5, 10, 20, hO or 50% sensitive cells were 
mixed with 95, 90, 80, 60, and 50^ normal cells, respectively. 
The cell mixtures were then tested in vitro for their sensi­
tivity to PPD. In addition, the normal and sensitive cells 
were tested individually. In several experiments, attempts 
were made to transfer MIF-mediated sensitivity in vitro from 
tuberculin-sensitive peritoneal cells to normal alveolar 
macrophages by the same methods. In one experiment, purified 
peritoneal lymphocytes, obtained by the Petri Dish Adsorption 
Method, were mixed with an equal number of normal alveolar 
macrophages prior to in vitro testing in the presence of ap­
propriate concentrations of PPD. In another experiment, 
peritoneal and alveolar cells obtained from the same sensitive 
donors were mixed in various proportions prior to jni vitro 
assay.
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Effect of Serum from Normal and Sensitive 
Guinea Pigs on Macrophage Migration
The effect of serum from normal and tuberculin- 
sensitive guinea pigs on the in vitro reactivity to PPD of 
normal and sensitive cells was studied next. Tissue culture 
medium (EMEM) was prepared containing either 15^ pooled nor­
mal guinea pig serum or pooled serum from tuberculin- 
sensitive donors which had been sensitized 3 weeks previously. 
All sera were heat-inactivated at 56 C for 30 min. Appropri­
ate concentrations of PPD were added to a portion of each 
medium. Leighton tubes were filled with 1.0 ml of the appro­
priate medium, with or without PPD. Peritoneal or alveolar 
cells obtained from normal or sensitive animals were suspended 
in the medium containing either normal or sensitive serum to 
a final concentration of approximately 1.5 x 1 o'̂ cells/ml. 
Finally, the cells were placed in capillary tubes and assayed 
for in vitro sensitivity to tuberculin as described previ­
ously. In a similar experiment, the effect of serum collected 
at 1 , 2, and 3 weeks post-sensitization on the in vitro sen­
sitivity of alveolar macrophages to tuberculin was determined.
Effect of Cortisone on In Vitro Sensitivity 
and Skin Reactivity to Tuberculin
Intraperitoneal Injection of Cortisone 
Normal and tuberculin-sensitive guinea pigs were in­
jected intraperitoneally with 30 ml of sterile paraffin oil 
72 hr prior to cell collection. Twenty-four hours prior to 
sacrifice, animals from each group were injected
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intraperitoneally with ^ ml of a suspension containing 0, 25? 
50, or 100 mg of cortisone acetate25 (25 mg/cc) diluted in 
pyrogen-free 0.85# NaCl. The cells were harvested as de­
scribed previously and tested for their in vitro sensitivity 
to 5 and 15 meg PPD/ml.
In Vitro Treatment of Peritoneal 
Cells with Cortisone
Pooled normal and tuberculin-sensitive peritoneal 
cells were divided into 3 equal aliquots and suspended in 
EMEM-S which contained either 0, 100, or 200 meg cortisone 
acetate/ml. The cell suspensions were then incubated on a 
roller drum^^ at 37 C for *+5 min. After incubation, the cells 
were washed once in 5 ml EMEM-S and resuspended in the same 
medium. Finally, the cells were tested in vitro for sensi­
tivity to 10 meg PPD/ml. In a second experiment, peritoneal 
cells from 3 sensitive guinea pigs (mean skin reactivity of 
20 mm induration) were divided into 3 equal aliquots and in­
cubated with cortisone by the methods used in the previous ex­
periment. After incubation, the cortisone-treated cells were 
washed once in 5 ml of EMEM-S and resuspended in EMEM-S con­
taining 0, 100, or 200 mcg/ml of cortisone corresponding to 
the concentrations the same cells had been incubated with pre­
viously. The cells were then tested in vitro for sensitivity 
to 5 and 10 meg PPD/ml.
^^Merck Sharp and Dohme, West Point, Pennsylvania.
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Cole Parmer Company, Chicago, Illinois.
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Effect of Intramuscular Cortisone Treatment 
on the Induction and Expression of 
Delayed Hypersensitivity 
to Tuberculin
The effect of the intramuscular injection of 
tuberculin-sensitive animals with cortisone on the expression 
of skin reactivity and in vitro sensitivity to tuberculin was 
studied. Groups of normal guinea pigs were sensitized with 
5 mg of H3/Rv antigen and sacrificed 21 days later. Five days 
prior to sacrifice, one group was injected intramuscularly 
with 10 mg cortisone daily for 5 days (total dosage, 50 mg).
A second group was injected in the same manner with 20 mg of 
cortisone daily (total dosage, 100 mg). Control groups con­
sisted of normal animals injected with cortisone. Skin tests 
were administered 2^ hr prior to initiation of cortisone ther­
apy and again 2h hr prior to sacrifice. Oil-induced perito­
neal exudate cells from each donor were assayed for in vitro 
sensitivity to 15 meg PPD/ml.
In order to study the effect of cortisone on the in­
duction of tuberculin hypersensitivity, k groups of 5 normal 
guinea pigs were treated as follows: Group 1 was injected
subcutaneously in the nuchal area with a mixture of 25 mg cor­
tisone and 5 mg of the Hg/Rv antigen which had been homogen­
ized in a Sorval omnimixerGroup 2 was injected intramus­
cularly in the groin with 20 mg cortisone acetate daily for 
5 days prior to sensitization and for 5 days post-sensitization
^^Ivan Sorvall, Inc., Norwalk, Connecticut.
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(total dosage, 200 mg); Group 3 was Injected intramuscularly 
with 20 mg of cortisone daily for 5 days prior to sensitiza­
tion and for 20 days post-sensitization (total dosage, 500 
mg); and Group ^ constituted the non-cortisone treated 
tuberculin-sensitive controls. Cortisone-treated normal ani­
mals corresponding to the first 3 groups were not sensitized 
and comprised the cortisone-treated, non-sensitized controls. 
The remainder of the animals were sensitized by the subcuta­
neous injection of 5 of H37Rv antigen in the nuchal area. 
Each animal was skin tested at weekly intervals for 4 weeks. 
The final skin tests were performed 2k hr prior to sacrifice 
of the animals. Skin test sites were biopsied from the sacri­
ficed animals and saved for histological studies. Approxi­
mately 21 days following sensitization, peritoneal exudates 
were harvested from donor animals which had been injected in­
traperitoneally with 30 ml sterile paraffin oil 72 hr previ­
ously. The cells from each donor were studied for their in 
vitro sensitivity to 15 meg PPD/ml.
Statistical Analyses 
Statistical analyses were made using a correlation co­
efficient or a one-tailed Student T Test (Dunn, 1966). Dif­




The initial phase of this investigation involved the 
determination of the optimal methods for rendering normal 
guinea pigs hypersensitive to mycobacterial antigens. For the 
purpose of determining the best route of sensitization, 2 
groups of 12 normal guinea pigs were injected either intra­
muscularly or subcutaneously with 5 mg of H37Rv antigen. To 
determine whether injection by dual routes might enhance sen­
sitization, a third group of 12 animals was injected both in­
tramuscularly and subcutaneously with 5 mg of the antigen 
(total dosage=10 mg). Results of weekly skin tests of the 
animals in each group for ^ weeks following sensitization in­
dicated that the intramuscular route was the least effective 
of the 3 routes tested (Table 1). This conclusion was based 
on the size of the skin reactions, as well as the central ne­
crosis, displayed in the animals 3-^ weeks post-sensitization. 
Dual sensitization by both routes seemed to offer no particu­
lar advantage over the subcutaneous route alone.
The effect of various doses of sensitizing antigen on 
the progressive development of tuberculin skin reactivity was
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TABLE 1
EFFECT OF ROUTE OF INJECTION ON THE DEVELOPMENT OF 
TUBERCULIN SKIN REACTIVITY IN GUINEA PIGS
Mean Skin Test Reactions 
(mm Induration)
at 2h Hr.
Route of Sensitization 
(Dose)










1 9 15 15
2 1^ 18 18
3 16 20 CN^ 20 CN
18 23 CN 23 CN
^•Central necrosis.
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studied next. Four groups of normal guinea pigs were injected 
subcutaneously with 0.5, 1.0, 5.0, or 10.0 mg of H3yRv anti­
gen. Skin tests were performed at weekly intervals for 3 
weeks following sensitization. Skin reactivity increased 
progressively in each group throughout the study (Table 2).
At the first week following sensitization, the animals in­
jected with 5 and 10 mg of antigen displayed stronger skin re­
activity than those sensitized with the lower doses. How­
ever, no detectable differences were noted in the various 
groups at 2 and 3 weeks post-sensitization. The apparent uni­
formity of the response was further supported by the simul­
taneous development of central necrosis in the skin test sites 
in all groups of animals at 3 weeks post-sensitization. Most 
of the animals also developed a necrotic breakdown of the tis­
sue at the site of injection of sensitizing antigen at approx­
imately 3“̂  weeks after sensitization. This response appeared 
at a time when skin reactivity was maximal.
Prior to studying delayed hypersensitivity to tuber­
culin in vitro it seemed desirable to attempt passive transfer 
experiments using the same methods of sensitization and in­
ducement and collection of peritoneal exudates that would be 
used later for in vitro studies. To accomplish this, a pre­
liminary experiment was performed in which sensitive donors 
with relatively weak skin reactivity (i.e., mean induration of 
12 mm) were used. The results of passive transfer of viable 
and sonically disrupted cells to normal recipients were
TABLE 2
EFFECT OF SUBCUTANEOUS SENSITIZING DOSE OF H37Rv ANTIGEN 
ON THE DEVELOPMENT OF TUBERCULIN SKIN 
REACTIVITY IN GUINEA PIGS











0.5 6 11 20 21 CN®- \o
1 .0 5 11 18 20 CN
5.0 6 15 20 21 CN
10.0 16 17 20 CN
Central necrosis.
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inconclusive in this experiment since the 2k- hr skin test re­
action of a normal control animal injected only with PPD was 
of the same size (approximately 5-7 mm induration) as those in 
the sensitive cell recipients. Results obtained in a second 
passive transfer experiment are presented in Table 3* Only 
intact viable cells from highly sensitive donors (i.e., mean 
induration of 22 mm) were capable of transferring tuberculin 
skin reactivity to normal recipients. Sonic-disrupted cells 
prepared from the same pooled cell suspension were incapable 
of transferring sensitivity. Neither intact or sonic- 
disrupted cells from donors with weaker skin reactivity (i.e., 
mean induration of 15 mm) nor viable cells from normal ani­
mals transferred sensitivity. It should be noted that all 
recipient animals in this experiment displayed transient skin 
reactions consisting of approximately 4— 6 mm of erythema 24 
hr after injection of PPD. These reactions disappeared by
4-8 hr with the exception of the recipients injected with vi­
able cells from H37Rv-sensitized donors. The latter reactions 
were well indurated and remained so at the 4-8 hr reading.
The problem of transient skin reactions observed early 
in this study in normal guinea pigs that had been injected 
with 5 meg PPD was considered to be the result of one of the 
following possibilities: (1) acquired or native low grade
sensitivity of "normal" animals; (2) non-specific reactivity 
of normal animals to the skin test materials (PPD antigen 
and/or diluent); (3) non-specific trauma due to the injection
TABLE 3
PASSIVE TRANSFER OF DELAYED SKIN REACTIVITY TO TUBERCULIN 
BY MEANS OF VIABLE AND SONICALLY DISRUPTED 
PERITONEAL EXUDATE CELLS








Time of Skin Test 
Day 3
After Cell Transfer 
Day 6
Sensitive (H37Rv): 
Intact Cells 22 15 10Sonic Lysate 0 0
Sensitive (H37Ra):
Intact Cells 15 0 0Sonic Lysate 0 0
Normal:
Intact Cells 0 0 0
ON
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of the skin test antigen. To study these possibilities, 3*+ 
newly acquired "normal" male albino guinea pigs were skin 
tested with 5 meg PPD diluted in the commercial phosphate 
buffer provided by the manufacturer. All of these animals de­
veloped 3-5 mm areas of erythema after 2^ hr which completely 
disappeared after ^8 hr. To test for possible non-specific 
effects of the commercial diluent, h normal guinea pigs were 
shaved on both sides. Two of the animals were injected on one 
side with 5 meg (0.1 ml) PPD prepared in commercial phosphate 
buffered diluent. Both animals were injected on the opposite 
side with 0.1 ml of the diluent alone. Two other normal ani­
mals received the same treatment with the exception that 
pyrogen-free 0.85^ BaCl (PF-saline) was substituted for the 
phosphate buffer as the diluent. Results (Table -̂) indicated 
that non-specific reactions occurred with PPD diluted in the 
commercial diluent as well as with the diluent alone. The use 
of PF-saline as a diluent eliminated the non-specific skin re­
activity. To determine if non-specific skin reactivity was an 
isolated incident associated with a particular lot of the com­
mercial diluent, 5 different lots of the commercial diluent 
were tested in the same manner. All of the diluents produced 
the same transient erythematous response. Again, a control 
animal injected with PF-saline showed no reaction. Throughout 
the remainder of this work non-specific skin reactivity was 
avoided by the use of PF-saline as a diluent for PPD.
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TABLE
COMPAEISON OF THE EFFECTS OF COMMERCIAL PHOSPHATE 
BUFFER AND PYROGEN-FREE SALINE AS DILUENTS 
FOR PPD ON NON-SPECIFIC SKIN REACTIVITY 







2k Hr 1+8 Hr
PPD in Phosphate 1 1+ 2
Buffer 2 0
Phosphate Buffer 1 1+ 0
2 0
PPD in Pyrogen- 3 0 0
Free Saline 0 0
Pyrogen-Free 3 0 0Saline !+ 0 0
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Different incubation times have been used, by various 
workers for recording the results of macrophage migration in 
the in vitro system. Most workers have recorded the results 
after incubation at 37 C for 24 and/or 48 hr. In order to de­
termine the optimal incubation time for recording cell migra­
tions in the in vitro system, 2 types of time studies were 
performed. In the first experiment (Table 5? Experiment A), 
migration of oil-induced peritoneal exudate cells from a 
single sensitive donor was followed by repeated readings of 
each tube after incubation at 37 C for 4, 8, 1 8, and 24 hr. 
Each value represents the mean of 8 different migration tubes. 
Results of a similar experiment are shown in Table 7, Experi­
ment B. In this experiment, four identical sets of tubes were 
prepared with pooled sensitive peritoneal cells and each set 
was read at a single time interval. Results were similar in 
both experiments. Leukocyte migration increased progressively 
throughout the first 18 hr of the study. Maximal cell migra­
tion and inhibition of migration occurred after 18 hr incuba­
tion. Essentially no changes occurred after incubation for 
24 hr.
In preliminary in vitro macrophage migration studies, 
concentrations of PPD (17, 20, and 30 mcg/ml) which had been 
used by other workers to detect in vitro sensitivity were 
found to inhibit the migration of normal cells and in some 
instances caused sloughing of macrophages from coverslips.
The toxicity was thought to be due to the cresol derivatives
TABLE 5
EFFECT OF INCUBATION TIME ON THE DEVELOPMENT OF MAXIMAL 
CELL MIGRATION AND INHIBITION OF MIGRATION 
OF SENSITIVE PERITONEAL CELLS








A 0 132 200 339 339
5 58 85 110 110
Percent Migration: h2 32 32
B 0 133 165 4-32 4-50
5 70 70 108 134-
Percent Migration: 53 4-2 25 30
o\
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used as preservatives in the commercial PPD preparation being 
used. For this reason, an endpoint titration method was de­
veloped to determine the least toxic concentration of PPD 
which would detect in vitro sensitivity. For this purpose, 
both normal and sensitive peritoneal cells, pooled from 2 
donor animals, were tested in vitro in the presence of 0, 5? 
10, 15, and 20 mcg/ml of a commercial PPD preparation. Re­
sults of this experiment are presented- in Table 6. All con­
centrations of PPD inhibited the migration of both normal and 
sensitive cells to varying degrees. In general, the Mean Per­
cent Migration decreased with increasing concentrations of PPD 
and the sensitive cells were inhibited more than were normal 
cells. Results of a similar titration experiment with lower 
concentrations of the same PPD preparation are presented in 
Table 7* These results were very similar to those seen in the 
previous experiment, although the pooled sensitive peritoneal 
cells used in this experiment were more sensitive to PPD. The 
migration of normal cells in the presence of 5 meg PPD was 
very similar to that observed in the previous experiment.
From these results, it appeared that 0.5 meg of PPD was the 
optimal concentration for this particular lot. However, this 
was investigated further in a subsequent experiment wherein 
peritoneal cells from 3 highly sensitive guinea pigs were com­
pared with cells from 3 moderately sensitive donors for their 
in vitro sensitivity to 0.5 and 5-0 meg PPD. To accomplish 
this, peritoneal exudate cells were pooled from 3 highly
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TABLE 6
IN VITRO ENDPOINT TITRATION OF HIGH CONCENTRATIONS 
OF A COMMERCIAL PPD PREPARATION 
CONTAINING PRESERVATIVES
Mean Percent Migration
PPD Concentration (mcg/ml) 
Cell Type 0 5 10 15 20
Normal 100 72 39 39 29
Sensitive 100 k2 12 1^ 7
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TABLE 7
IN VITRO '.ENDPOINT TITRATION OF LOW CONCENTRATIONS 




Cell Type 0 0.5 1 .0 2.5 5.0
Normal 100 91 78 75 68
Sensitive 100 ^1 37 23 18
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sensitive donors (mean skin reactivity = 31 mm induration, 
with central necrosis) which had been dually sensitized both 
subcutaneously and intramuscularly with 5 mg H37Rv antigen 8 
weeks previously. Cells were obtained from 3 moderately sen­
sitive donors (mean skin reactivity = 20 mm induration) which 
had been sensitized 3 weeks previously by subcutaneous injec­
tion of 5 mg H37Rv antigen. Cells from the highly sensitive 
donors were inhibited in vitro by both 0.5 and 5*0 meg con­
centrations of PPD while those from the less sensitive ani­
mals were inhibited by only the 5*0 meg concentration (Table 
8). Since 5 meg of PPD was effective in detecting low grades 
of sensitivity in vitro, with minimal toxicity for normal 
cells, this concentration was used for subsequent experiments.
The results of a series of experiments in which cells 
from normal and sensitive animals were tested in vitro in the 
presence of 5 meg of PPD containing preservatives are pre­
sented in Table 9* Typical patterns are shown in Figure 1.
The cells from sensitive animals were markedly inhibited by 
5 meg of PPD/ml in comparison with those from normal animals. 
There was a statistically significant correlation between the 
inhibition of migration and the diameter of the skin reac­
tions in this group of animals.
It had been postulated that the non-specific in vitro 
toxicity of commercial PPD preparations was due to the cresol 
derivatives which had been added as preservatives. The pre­
servatives apparently had no detectable effect on skin tests,
TABLE 8
EFFECT OF PPD CONCENTRATION ON THE DETECTION OF 
IN VITRO SENSITIVITY OF PERITONEAL CELLS 
FROM SENSITIVE GUINEA PIGS
Mean Percent Migration
Cell Type
Mean Skin Reactivity 
(mm Induration)
PPD Concentration (mcg/ml) 
0.5 5.0
Normal 0 83 71
Highly Sensitive 31 CN^ >+3 19




PERCENT MIGRATION OF PERITONEAL CELLS FROM NORMAL AND TUBERCULIN-SENSITIVE 














S-1 32 ON®- 10 N-1 72
S-2 16 42 N-2 68
8-3 16 46 N-3 84S-̂ - 20 CN 18 N-4 84
s-5 28 ON 6 N-5 71
S-6 26 CN 26 N-6 90
8-7 18 46 N-7 70S-8 20 CN 32 N-8 1138-9 16 35 N-9 1018-10 20 38 N-10 75S-11 18 37 N-11 77
S-1 2 20 32 N-1 2 74
8-13 20 30 N-13 76
S-^k 18 4is- 1 5 20 CN ^3 Mean: 80s-1 6 22 CN 12
S-17 22 CN 11
S- 1 8 22 CN 20










Figure 1.— Migration of peritoneal cells from normal 
and tuberculin-sensitive guinea pigs in the presence or 
absence of PPD.
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since no reactions were seen when PPD was injected into the 
skin of normal guinea pigs. In order to explore this phenom­
enon further, a PPD preparation was obtained which contained 
no preservatives or additives. In these experiments, peri­
toneal cells from several normal and sensitive donors were 
tested individually in vitro with various PPD concentrations. 
Sensitive cells were obtained from donors that had been in­
jected subcutaneously with 5 mg H37Rv antigen 3-^ weeks previ­
ously. Results of endpoint titration experiments using the 
PPD preparation without preservatives are summarized in 
Table 10. Non-specific inhibition of normal peritoneal cells 
was not observed in these experiments. However, there was a 
slight stimulation of migration of normal cells in the pres­
ence of all PPD concentrations tested. This was not a con­
sistent finding, however, since in later experiments occa­
sional inhibition of normal cell migration by high concentra­
tions of PPD without preservatives was observed. Sensitive 
peritoneal cells were significantly inhibited by all concen­
trations of PPD tested. Although as little as 1.0 meg of PPD 
was effective in detecting in vitro sensitivity, the results 
suggested that 5 meg was the endpoint concentration for this 
particular PPD preparation. It should be noted that the end­
point concentrations for PPD preparations with and without 
preservatives were identical.
In order to compare the relative effectiveness of the 
PPD preparations, a series of experiments was done in which
TABLE 10





Mean Percent Migration 
PPD Concentration (mcg/ml)
2 . 5  5 . 0 1 0 .0 1 5 .0 2 0 . 0
Normal
N -1 127 119 126 126 104 .__a
N-2 143 124 157 119 102 — —
N-3 — -- 108 112 1 0 3 116
Sensitive
S-1 39 26 20 25 2 2 --
S-2 26 30 31 30 30 --
8-3 — —  =_ 21 17 18 17
8-4 — — 29 28 21 20
s-5 — ■“ — — 2 9 3 2 2 5 31




normal and sensitive peritoneal cells were tested in vitro in 
the presence of 5 meg PPD with preservatives and 15 meg PPD 
without preservatives. The results of this experiment, which 
are presented in Table 11, indicated that 5 meg of PPD with 
preservatives was equivalent to 15 meg of PPD without preser­
vatives in inhibiting both normal and sensitive cell migra­
tion.
It seemed pertinent to determine the optimal time in­
terval following sensitization for the detection of in vitro 
sensitivity to PPD. Also, it seemed desirable to determine 
whether there was any correlation between the development of 
tuberculin skin reactivity and in vitro cellular sensitivity. 
In a preliminary qualitative experiment, 16 normal guinea pigs 
were sensitized by intramuscular injection of 5 mg H3?Rv anti­
gen. Half of the animals were reserved for skin testing, 
while peritoneal cells from 2 representative animals of the 
remaining group were studied in vitro at weekly intervals by 
methods described previously. The results indicated that in 
vitro sensitivity was not demonstrable until 3 weeks post­
sensitization whereas significant skin reactivity could be de­
tected at one week. In a similar experiment, animals sensi­
tized by the subcutaneous route were followed for a 5 week 
period. Appreciable skin reactivity was noted as early as 
1-2 weeks post-sensitization, and it increased throughout the 
study (Table 12). However, significant cellular sensitivity 
could not be detected until 3 weeks post-sensitization. It
TABLE 11
COMPARISON OF THE EFFECTS OF PPD WITH AND WITHOUT PRESERVATIVES 






PPD With Preservatives 
(5 mcg/ml)
PPD Without Preservatives 
(15 mcg/ml)
Normal N-1 76 75N-2 77 75
N-3 76 75N-^ 102 1 1 3Mean: 83 84
Sensitive S-1 19 20
S-2 14 12
8-3 9 68-4 29 22
s-5 10 12S-6 1 5 198-7 4 10
S-8 20 1 5
S-9 51 50S-10 7 1 1s- 1 1 7 10s-1 2 13 16
8-13 18 18Mean: 17 17
ON
TABLE 12
DEVELOPMENT OF SKIN REACTIVITY AND IN VITRO CELLULAR SENSITIVITY IN 




Mean Skin Reactions 
(mm Induration)
Mean Percent Migration 
(5 meg PPD/ml)
Sensitive 1 1>+ (5)^ 83 (3 )
2 18 (51 73 (3)
3 28 (5) CN^ (3)
1+ 28 (5) CN 1+2° (3)
5 (5) CN 33C (2)
Normal 76 ih)
^Number of animals 
^Central necrosiso
'P = 0 .05.
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appeared from these results that IjQ, vitro cellular sensitivity 
to PPD developed more slowly than did skin reactivity.
It seemed possible that the slower development of in 
vitro cellular sensitivity, as compared with skin reactivity, 
might be due to one or more of several factors: (1) The con­
centration of PPD (containing preservatives) used for the de­
tection of in vitro cellular sensitivity may have been too low 
to detect minimal levels of sensitivity during the induction 
phase; (2) excess sensitizing antigen (i.e., 5 mg H37P^ anti­
gen) might have preferentially blocked the expression of in 
vitro cellular sensitivity by some unknown mechanism, which 
could presumably be similar to immune tolerance; (3) subtle 
differences may exist in the basic mechanisms of MIF-mediated 
sensitivity in vitro and dermal sensitivity which might ex­
plain the discrepancy in their time of development; and ()+) 
either the number or distribution of immunocompetent lympho­
cytes in the sensitized animal during the early stages of in­
duction may be such that the expression of skin reactivity 
precedes in vitro cellular sensitivity.
In order to test the possibility that excess amounts 
of sensitizing antigen had delayed the expression of in vitro 
sensitivity during the induction period, an experiment was 
designed to examine the effect of low and high doses of anti­
gen on the development of in vitro sensitivity. For this pur­
pose 3 groups of normal guinea pigs were sensitized with 1.0,
5-0, or 10.0 mg H37Rv antigen by the methods described
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previously. Peritoneal cells from 2 selected non-skin tested 
donors from each group were tested at weekly intervals in 
vitro in the presence of 5 meg PPD without preservatives. The 
remaining sensitive animals in each group were reserved for 
skin testing. The results of this experiment are presented 
in Table 13- The immune response of the animals in this ex­
periment was not as uniform as it had been in previous 
studies. In vitro sensitivity was not detected until 2 weeks 
post-sensitization in 1 of 2 animals sensitized with 1.0 mg of 
antigen. Cells from 1 of 2 animals sensitized with 5 mg of 
mycobacterial antigen were inhibited at 1 week post­
sensitization, but no in vitro sensitivity could be detected 
in animals from the same group after 2 weeks. Peritoneal 
cells obtained from 2 donors sensitized with 10 mg of antigen 
were first inhibited at 2 weeks post-sensitization. Cells 
from all 3 groups of animals were inhibited in vitro 3 weeks 
following sensitization. No definite pattern was observed in 
the induction of in vitro sensitivity with varying amounts of 
sensitizing antigen. It should be noted at this point that 
the relative uniformity of the immune response observed in 
previous experiments may have been fortuitous since Ferraresi, 
et al. (1969)5 in a similar study, reported variation in the 
time required for the induction of in vitro sensitivity to 
tuberculin in individual animals in a group of guinea pigs 
sensitized with mycobacterial antigen. This phenomenon was 
studied further in the next experiment in which a larger
80
. TABLE 13
THE EFFECT OF SENSITIZING ANTIGEN DOSE ON THE 
DEVELOPMENT OF SKIN REACTIVITY AND 
IN VITRO CELLULAR SENSITIVITY






Skin Reaction 4-/4- 4/41 .0
In Vitro 
Inhibition 0/2^ 1/2 2/2
Skin Reaction k / k 4/4- 4/45.0
In Vitro 
Inhibition 1/2 0/2 2/2
Skin Reaction h / k 4/4 4/410.0
In Vitro 
Inhibition 0/2 2/2 2/2
^Number of animals with more than 12 mm induration/
total.
Number of animals with less than /O^ in vitro 
migration/total.
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number of animals was used. Two groups of 16 animals were 
sensitized subcutaneously with either 0.5 or 5-0 mg of 
antigen. Peritoneal cells were collected at weekly intervals 
from representative non-skin tested donors of each group and 
tested in vitro using 15 mcg/ml of PPD without preservatives 
by the methods described previously. The uniform early and 
progressive development of dermal sensitivity in both groups 
during the 3 week experimental period was again confirmed 
(Table l43. In vitro sensitivity first appeared at a time 
when skin reactivity was nearly maximal (i.e., 2 weeks after 
sensitization).
In a preliminary study of alveolar macrophages, lung 
washings containing 90-95^ alveolar macrophages obtained from 
7 donors with known dermal sensitivity (i.e., 20 mm indura­
tion) were studied in vitro for their cellular sensitivity to 
PPD by the macrophage migration method. The results indicated 
that alveolar cells from sensitive donors were not inhibited 
significantly by 5 or 20 mcg/ml of PPD (Table 1 5) - Typical 
migration patterns are shown in Figure 2.
In the next experiment, the in vitro sensitivity of 
peritoneal cells and alveolar cells obtained from the same 
donors was compared. For this purpose, both peritoneal and 
alveolar cells were collected from 2 normal and 2 sensitive 
donors and tested in vitro by the methods described previ­
ously. The results of this experiment are presented in Table 
16. Peritoneal cells from the sensitive animals were
TABLE l4
EFFECT OF HIGH OR LOW SENSITIZING ANTIGEN DOSAGE ON THE 













1 4- 10 98
0.5 2 M- 20 39
3 4 22 CN^ 31
1 12 96
5.0 2 20 4-8
3 !+ 2h CN 3’+
1 1+ __c 102
0 2 2 - 102
3 2 - 102
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ABSENCE OF IN VITRO SENSITIVITY OF ALVEOLAR 
CELLS FROM GUINEA PIGS OF KNOWN 
SKIN REACTIVITY
Cell Type AnimalNo.
PPD Concentration (mcg/ml) PercentMigration






8-7 20 84 ■
Mean: 96









Cells From Tuberculin 
Sensitive Donor
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Figure 2. Migration of alveolar cells from normal 




COMPARISON OF IN VITRO SENSITIVITY OF PERITONEAL AND 
ALVEOLAR CELLS OBTAINED FROM THE SAME DONORS
Cell Type
Skin Reactivity 
(mm Induration) Cell Type
Percent
Migration?’











significantly inhibited by PPD, ■while alveolar cells from the 
same animals were not. The migration of peritoneal and al­
veolar cells from the normal animals was not inhibited by PPD.
The failure to demonstrate alveolar cell sensitivity 
in animals injected by the subcutaneo-us route led to the in­
vestigation of a different method of sensitization. Heise et 
al. (1968) reported the induction of alveolar cell sensitivity 
to PPD in the guinea pig by a specific method of sensitiza­
tion. These workers attributed the cellular sensitivity as 
being due to a cell-bound antibody which was cytophilic for 
the alveolar macrophage, rather than to Migration Inhibitory 
Factor. An experiment was performed in which k normal animals 
were sensitized with H37Rv antigen by the method of Heise et 
al. (1968), as described previously. Alveolar cells were col­
lected from the >+ sensitized guinea pigs and from ^ normal 
animals ^ weeks after sensitization and tested in vitro for 
sensitivity to 15 meg PPD. Oil-induced peritoneal exudates 
were collected from the sensitive alveolar cell donors and 
studied in vitro by the same method. Skin tests which were 
performed 24- hr prior to cell collection revealed that the 
mean skin reactivity of the sensitive animals was 24- mm in­
duration, with central necrosis (Table 17). Although skin 
reactivity was pronounced in all of the sensitive animals, 
only minimal inhibition of alveolar cell migration was de­
tected in vitro. Peritoneal cells obtained from 2 of the 
donor animals were inhibited significantly in the presence of
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TABLE 17
EFFECT OF SENSITIZATIOT BY THE METHOD OF 
HEISE ET Mj. (1968) ON IN VITRO 

















•̂1 5 meg PPD/ml. 
^Central necrosis.
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PPD. These results suggested that pronounced alveolar cell 
sensitivity could not be demonstrated by the techniques used, 
even though skin reactivity and peritoneal cell sensitivity 
were clearly demonstrated.
Differential leukocyte counts on Wright’s stained 
smears of all cell suspensions obtained from guinea pig lung 
washings revealed 90-95^ alveolar macrophages. Virtually no 
lymphocytes were present. It seemed possible that the lack 
of alveolar cell sensitivity in the present study might be 
due to the absence of sufficient quantities of immunocompe- ,
' tent lymphocytes. For this reason attempts were made to in­
duce the infiltration of immunocompetent cells (i.e., lympho­
cytes) into the guinea pig lungs by several different methods.
It seemed possible that the failure to induce alveo­
lar cell sensitivity to PPD in earlier experiments may have 
been due to the route of sensitization used. Subcutaneous 
injection of antigen presumably did not promote direct ex- ■ 
posure of lung tissue to the mycobacterial antigen. This as­
sumption was supported by the observation that the gross ap­
pearance of lungs from sensitive animals was indistinguish­
able from that of normal animals in being free of inflamma­
tion or granulomatous lesions. In addition, there were no 
inflammatory cells in the lung washings from these animals. 
These observations suggested that the lung tissue must come 
in direct contact with the sensitizing antigen before cellu­
lar sensitivity can develop. To accomplish this, two groups
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of normal animals were injected intravenously in the foreleg 
with 1 .5 mg or 2 . 5 mg of mycobacterial antigen by the methods 
described previously. A third group of animals was injected 
intracardially with 2 . 5  mg of the same antigen preparation.
A final group of animals was injected by the intrapleural 
route directly into the lobe of the lung with CFA containing
2.5 mg of heat-killed H37Rv cells. Alveolar cells were col­
lected 4- weeks post-sensitization and tested in vitro for 
sensitivity to 15 meg PPD by the methods described previously. 
Due to technical difficulties, alveolar cells were not ob­
tained from some of the sensitive donors. The results pre­
sented in Table l8 indicate that intravenous and intrapleural 
injection of antigen were ineffective in inducing alveolar 
cell sensitivity, although dermal sensitivity was demonstrable 
in certain of these animals. Alveolar cells from 3 animals 
sensitized by the intracardial route were inhibited slightly 
by PPD in vitro. Differential counts revealed that all of 
the lung cell suspensions from both sensitized and normal 
donors contained 9 0-95^ alveolar macrophages and 5-10^ lymph­
ocytes. The gross appearance of the lungs of the animals in­
jected with mycobacterial antigen directly into the lungs was 
definitely altered. Extensive adhesions were observed in the 
chest cavity. Nodules of fibrosis covered the outer surface. 
Extensive fibrosis was evident throughout the lung tissue and 
the lobes were firm rather than spongy in consistency. Based 
on the gross pathological changes, it was surprising that the
90
TABLE 18
EFFECT OF SENSITIZATION BY THE INTRACARDIAL, 
INTRAVENOUS, OR INTRAPLEURAL ROUTES ON 
THE IN VITRO SENSITIVITY OF GUINEA 











1 . 5 mg 2 __L 95
2 . 5 mg 3 16 CNC 90
Intracardial
2 - 5 mg 3 18 CN y2d
Intrapleural
2 . 5 mg 3 — — 86
Normal 5 - 9!+






cells collected from the alveolar spaces of these lungs showed 
no increase in the number of inflammatory cells. Minor 
changes in gross appearance were noted in the lungs of ani­
mals sensitized by the intravenous and intracardial routes.
In general, this consisted of no more than a few solid nodules 
in one or more lobes of the lung. These results suggested 
that the alveolar cells were obtained from the remaining 
healthy areas of the lung in these animals. Since the areas 
of pathology in the lungs were completely walled off by fi­
brosis, inflammatory cells probably could not be obtained by 
the methods of collection used.
The failure to demonstrate high levels of alveolar 
cell sensitivity in the earlier experiments led to attempts 
to induce the release of Migration Inhibitory Factor (MIF) in 
vivo by intracardiac challenge of sensitive animals. It 
seemed possible that systemic challenge of the animals with 
PPD might induce the release of MIF in sufficient quantities 
to passively sensitize alveolar macrophages in vivo. In the 
first experiment, sensitive (subcutaneous injection of 5 mg 
H37RV antigen) and normal animals were injected intracardi- 
ally with 25 meg of PPD 2k- hr prior to in vitro assay of their 
alveolar macrophages by the methods described previously. In 
a second experiment, 2 groups of sensitive animals which had 
been injected either intravenously or intracardially with
2 . 5  mg of mycobacterial antigen in 0.85% NaCl were injected 
intracardially with 1 mg PPD prior to in vitro studies on
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their alveolar cells. The skin reactions of all the animals 
measured 15 mm induration, or greater. Results of both ex­
periments are presented in Table 19- Under the conditions of 
these experiments, the challenge of sensitive animals with 
PPD had no effect on in vitro sensitivity of their alveolar 
macrophages.
It seemed possible that previous attempts to induce 
MIF-mediated sensitivity in the alveolar cell population of 
the guinea pig lung were unsuccessful due to the presence of 
inadequate numbers of immunocompetent lymphocytes. There­
fore, attempts were made to demonstrate alveolar cell sensi­
tivity by mixing the cells with peritoneal cell suspensions 
from sensitive animals which were known to contain sufficient 
quantities of immunocompetent cells. In the first experi­
ments, the in vitro migration of various peritoneal cell mix­
tures from normal and tuberculin-sensitive animals was tested 
in the presence of PPD. Cell mixtures containing 10, 40, and 
50^ sensitive and 90, 60, and 50^ normal cells, respectively, 
were inhibited in vitro in the presence of PPD (Table 20).
The degree of inhibition of migration increased with the in­
crease in the number of sensitive cells in the cell mixtures.
In the next experiment, peritoneal exudate cells and 
alveolar cells from the same sensitive donors were collected, 
mixed in various proportions, and tested in vitro against 5 
mcg/ml PPD by the methods described previously. Results of 
this experiment are presented in Table 21. None of the h
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TABLE 19
EFFECT OF INTRACARDIAL PPD CHALLENGE OF SENSITIVE 
GUINEA PIGS 2k HOURS PRIOR TO CELL COLLECTION ON THE IN VITRO SENSITIVITY OF THEIR ALVEOLAR CELLS
Cell Type No. of Animals
Dosage











IN VITRO MIGRATION OF MIXTURES OF NORMAL 
AND SENSITIVE PERITONEAL CELLS IN 
THE PRESENCE OF PPD
Experiment
Percent Peritoneal Cell Mixture Mean Percent 
Migration^Sensitive Normal
0 100 88










IN VITRO MIGRATION OF MIXTURES OF PERITONEAL AND 
ALVEOLAR CELLS OBTAINED FROM THE SAME 




Mean Percent Migration®"Peritoneal Alveolar
0 100 101
100 0 22 b
1 10 90 111
20 80 9^
0 100 102
100 0 1 7 b
2 10 90 83
20 80 70^
0 100 103
100 0 5 2 ^
3 20 80 99
50 50 88
0 100 100





alveolar cell suspensions was inhibited by PPD, while all of 
the 100# peritoneal cell suspensions were inhibited. Cell 
mixtures from 3 of the k donors (animals no. 1, 3, â id *+) were 
not inhibited. However, in one instance, a cell mixture from 
a sensitive animal (animal no. 2), which consisted of 20# 
peritoneal and 80# alveolar cells was apparently inhibited 
significantly. It should be noted that the in vitro sensitiv­
ity of the peritoneal cells from this animal was greater than 
that displayed by the other guinea pigs used in this experi­
ment. These results suggested that peritoneal cells from 
only highly sensitive donors were capable of influencing the 
migration of alveolar cells. Further, only low levels of 
sensitivity were detected in alveolar cell mixtures as com­
pared to corresponding mixtures of peritoneal cells.
In order to compare the sensitivity of cell mixtures 
containing different cell types, an experiment was performed 
in which peritoneal cells from 2 highly sensitive guinea pigs 
were pooled and mixed in various proportions with either alve­
olar cells from the same donor animals or with peritoneal 
cells pooled from 2 normal animals. The cell mixtures were 
then tested in vitro by the methods described previously.
The results of this experiment (Table 22) revealed that mix­
tures of sensitive and normal peritoneal cells were much more 
sensitive to PPD than were corresponding mixtures of the same 
sensitive peritoneal cells and sensitive alveolar cells. Sig­
nificant inhibition of migration occurred with all of the
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TABLE 22
COMPARISON OF THE IN VITRO MIGRATION OF SENSITIVE 
PERITONEAL CELLS MIXED WITH EITHER NORMAL 










0 0 100 102
0 100 0 96
100 0 0 1 2b
5 0 95 87
10 0 90
20 0 80 70^
5 95 0
10 90 0
20 80 0 37^
^15 meg PPD/ml. 
^P=0.05.
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sensitive-normal peritoneal cell mixtures tested. Only the 
mixture of 20^ sensitive peritoneal and 80^ sensitive alveolar 
cells was inhibited significantly, although the other alveolar 
cell mixtures appeared to be inhibited slightly. As observed 
previously, the degree of inhibition was dependent on the 
concentration of sensitive cells in the cell mixtures.
Based on the previous experiments, it appeared that it 
might be possible to enhance the low levels of sensitivity of 
peritoneal-alveolar cell mixtures by increasing the number of 
immunocompetent lymphocytes in the cell mixture. An experi­
ment was performed in which a purified sensitive peritoneal 
lymphocyte suspension, pooled from 4- sensitive animals and ob­
tained by the Petri dish adsorption method described previ­
ously, was mixed with an equal quantity of alveolar cells, ob­
tained from the same donors, prior to in vitro assay. In this 
experiment, a 50^ mixture of sensitive lymphocytes and sensi­
tive alveolar macrophages was inhibited to a degree which was 
comparable to that seen with the sensitive cell control (Table 
2 3). These results, although preliminary in nature, confirmed 
that alveolar cells are capable of expressing cellular sensi­
tivity to PPD when the number of immunocompetent cells in the 
mixture is high.
Most workers have reported that humoral antibody in 
the form of serum obtained from sensitive animals, has no de­
tectable effect on MIF-mediated in vitro sensitivity of peri­
toneal cells. However, Heise ejt (1968) reported that
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TABLE 23
IN VITRO MIGRATION OF A MIXTURE OF POOLED PURIFIED 
PERITONEAL LYMPHOCYTES AND ALVEOLAR MACROPHAGES 
OBTAINED FROM THE SAME SENSITIVE GUINEA PIGS
Percent Cell Mixture






Pooled sensitive peritoneal cells prior to ad-
cperitoneal lymphocyte suspension after adsorption.
100
immune sera from BCG-sensitized guinea pigs enhanced the inhi­
bition of migration of alveolar cells from both normal and BCG- 
sensitive animals in vitro. In addition, it seemed possible 
that the low levels of sensitivity of alveolar cells from ani­
mals sensitized by various methods in previous experiments 
might be enhanced by immune serum. In order to test this pos­
sibility an experiment was performed in which normal and sen­
sitive peritoneal or alveolar cells were tested in vitro in 
tissue culture medium which contained 15^ pooled normal or im­
mune serum. Immune serum had little effect on the migration 
of normal or sensitive peritoneal cells (Table 2*+). In vitro 
sensitivity of alveolar cells from 2 animals sensitized by the 
method of Heise ^  al. (1968) was enhanced by the addition of 
pooled immune serum to the culture medium. The migration of 
normal alveolar cells was again stimulated by the immune 
serum, as was the case in the previous experiment with normal 
peritoneal cells.
In the previous experiments, sera from animals that 
had been sensitized 3 weeks previously were pooled and used 
as a source of immune serum. In the next experiment sera from 
animals sensitized subcutaneously with 5 mg antigen were
collected at 3 weekly intervals following sensitization and 
examined for their effect on the in vitro sensitivity of nor­
mal and sensitive alveolar cells. Alveolar cells were col­
lected and pooled from 2 normal and 2 sensitive animals (sen­
sitized by subcutaneous injection of 5 mg H37Rv antigen). In
101
TABLE 24
EFFECT OF IMMUNE SERUM ON THE IN VITRO SENSITIVITY ' OF PERITONEAL AND ALVEOLAR CELLS FROM NORMAL OR SENSITIVE GUINEA PIGS
Cell Type Cell Source
Mean Percent PMgration& 
Type of Serumb 
Normal Immune
Peritoneal Normal 90 104
Sensitive 36 3316 11
Alveolar Normal 99 11787 90
Sensitive 63 4375 64
®-1 5 meg PPD/ml.
^Fifteen percent normal or immune serum in EMEM.
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vitro tests were performed in media containing either 15^ nor­
mal or 15^ sensitive guinea pig serum collected at 1, 2, or 3 
weeks post-sensitization. From the results of this experi­
ment (Table 25), it was apparent that immune serum collected 
at 1 and 2 weeks post-sensitization had no effect on the mi­
gration of normal or sensitive alveolar cells. However, the 
immune serum collected at 3 weeks post-sensitization clearly 
enhanced the in vitro sensitivity of alveolar cells from sen­
sitive animals. A minimal effect on normal alveolar cell mi­
gration was observed with the same serum. These results sug­
gested that alveolar cells from sensitive animals are much 
more responsive to the effects of a humoral factor, which oc­
curs in immune serum collected 3 weeks after sensitization, 
than are alveolar cells from normal animals. Moreover, alve­
olar cells differ from peritoneal cells in that immune serum 
appears to have no effect on the in vitro sensitivity of the 
latter.
In order to determine the effect of intraperitoneal 
injection of cortisone on MIF-mediated cellular sensitivity of 
oil-induced peritoneal cells, 2 experiments were performed.
In the first experiment, 2 sensitive animals were each in­
jected intraperitoneally with either O.Q^% NaCl or 25, 50? or 
100 mg cortisone acetate 2h hr prior to collection of cells.
In vitro assay of their peritoneal cells was accomplished by 
the methods described previously. The results of this experi­
ment are presented in Table 26. No significant differences
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TABLE 25
EFFECT OF IMMJNE SERA COLLECTED AT VARIOUS TIMES AFTER 
SENSITIZATION ON THE IN VITRO SENSITIVITY OF 
NORMAL AND SENSITIVE ALVEOLAR CELLS
Mean Percent Migration®-
Alveolar Cell Donor
Weeks0 Post-1 ■Sensitization 2 3
Normal 97 99 95 82
Sensitive 89 84 94 47
'•15 meg PPD/ml; 1 5^ serim in EMEM.
^oh
TABLE 26
EFFECT OF INTRAPERITONEAL INJECTION OF CORTISONE 









Normal 1 None 91
Sensitive 2 Saline 18
2 25 mg cortisone 28
2 50 mg cortisone 10




were detected in the in vitro sensitivity of peritoneal cells 
from saline injected controls and those treated with 25 and 
50 mg of cortisone. However, 100 mg of cortisone partially 
suppressed in vitro sensitivity when compared to sensitive 
controls. In a second experiment, cells from sensitive ani­
mals which had been injected intraperitoneally with 100 mg of 
cortisone prior to assay again demonstrated partial suppres­
sion of in vitro sensitivity to PPD (Table 2 7)• Intraperi­
toneal injection of cortisone also reduced the total yields of 
exudate cells as compared to saline-treated controls, al­
though no affect on differential cell counts was noted.
These results suggested that peritoneal cells exposed in vivo 
to high concentrations of cortisone were affected in their in 
vitro sensitivity to PPD.
Experiments were also performed to determine the ef­
fect of in vitro cortisone treatment of peritoneal cells on 
macrophage migration and MIF-mediated sensitivity to PPD. For 
this purpose, pooled normal and sensitive peritoneal cells 
were Incubated with 0, 100, or 200 mcg/ml concentrations of 
cortisone prior to in vitro assay. The results of this ex­
periment are presented in Table 28. Treatment of normal and 
sensitive cells with cortisone resulted in stimulation of 
macrophage migration in the absence of PPD. This was evident 
by the values obtained for the mean areas of migration of the 
cortisone-treated cells in the absence of PPD as compared to 
the untreated controls. . The values for the mean area of
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TABLE 27
EFFECT OF INTRAPERITONEAL INJECTION OF CORTISONE 
ACETATE ON THE IN VITRO SENSITIVITY OF OIL 
INDUCED PERITONEAL CELLS TO PPD
No. of Mean Percent
Cortisone Treatment (mg) Animals Migration^
None 2 32
100 67^




EFFECT OF INCUBATION OF PERITONEAL CELLS WITH CORTISONE ACETATE ON SUBSEQUENT IN VITRO SENSITIVITY
Cell Type
CortisoneTreatment(mcg/ml)
Mean Area Migration (mm2 )
PPD Concentration (mcg/ml)
0 10 Mean Percent Migration
Normal 0 27^ 174- 63
100 4-16 119 28
2 0 0 689 118 17
Sensitive 0 577 272 4-7
100 704- 217 31
2 0 0 812 257 ■ 4-4-
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migration of normal cells migrating with PPD were very sim­
ilar. The stimulatory effect on migration noted in the ab­
sence of PPD was overcome in the presence of antigen. As a 
result of the stimulatory effect of cortisone on the migra­
tion of macrophages in the absence of antigen, the Mean Per­
cent Migration values obtained were highly variable. Thus 
cortisone treatment definitely stimulated macrophage migra­
tion, but evaluation of MIF-mediated sensitivity was not pos­
sible.
A second experiment was performed using the same 
methods, with the exception that after incubation with corti­
sone the cells were resuspended in tissue culture medium con­
taining the same concentrations of cortisone which had been 
used for incubation. Results of this experiment indicated 
that prolonged cortisone treatment of sensitive peritoneal 
cells inhibited the migration of macrophages in the absence 
of PPD (Table 29). Treatment with 200 meg cortisone appar­
ently inhibited the migration of sensitive macrophages non- 
specifically either in the presence or absence of PPD, as 
compared to non-treated controls. The migration of sensitive 
peritoneal cells which had been treated with 100 meg of cor­
tisone were not inhibited to the same degree in the presence 
of 5 and 10 meg PPD as compared to untreated controls. The 
Mean Percent Migration values were interpreted as indicating 
that the 100 meg concentration of cortisone was effective in 
suppressing the expression of MIF-mediated sensitivity to PPD.
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TABLE 29











Normal None 3^9 357 253 99 70
Sensitive None 351 143 83 4i 24
100 277 229 171 83b 62b
200 i>+5 46 54 32 37
®-PPD concentration (mcg/ml) 
bp=0.05.
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The effect of cortisone treatment on the skin reac­
tivity and in vitro sensitivity to PPD of fully sensitive 
guinea pigs was studied next. The effect of cortisone treat­
ment of tuberculin-sensitive guinea pigs with 5 daily intra­
muscular injections of 10 mg or 20 mg of cortisone acetate 
(total dosage of 50 mg and 100 mg, respectively) on the Mean 
Total Cell Yields and the Percent Mononuclear Cells of oil- 
induced peritoneal exudates is presented in Table 30. The 
Mean Total Cell Yield of exudates collected from sensitive 
animals treated with 100 mg of cortisone acetate were de­
pressed nearly three-fold when compared to untreated con­
trols. However, cortisone-treated normal animals were not 
similarly depressed in their cell yields. Treatment of sen­
sitive or normal animals with 50 mg of cortisone appeared to 
have no effect on the percent mononuclear leukocytes. How­
ever, the percentage of mononuclear cells was depressed in 
both groups treated with 100 mg cortisone. The effect of 
cortisone treatment on delayed skin reactivity and in vitro 
sensitivity to tuberculin is presented in Table 31• The mean 
skin reactivity of the untreated sensitive group was the same 
on day 0 and on day 5- The reactions of all of these animals 
were well indurated and displayed central necrosis. Both 
groups of sensitive animals treated with cortisone demon­
strated depressed skin reactivity after 5 days of cortisone 
injections. Although the skin test sites were moderately in­
durated, no central necrosis was observed in the
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TABLE 30
EFFECT OF INTRAMUSCULAR INJECTION OF TUBERCULIN 
SENSITIVE GUINEA PIGS WITH CORTISONE ON TOTAL 











Untreated 5 0.21 86
Cortisone 
50 mg 5 0 .1 5 96
Cortisone 
100 mg 5 0 .0 8 ^0^
Normal:
Untreated 2 0 .1 9 8i+
Cortisone 
50 mg 1 0 .1 3 94
Cortisone 




EFFECT OF INTEAMÜSCULAR INJECTION OF TUBERCULIN 
SENSITIVE GUINEA PIGS WITH CORTISONE ON 





Mean Skin Reactivity 
(mm)
Day 0 Day 5 Mean Percent Migration^
Sensitive:
Untreated 5 21 CN^ 21 ON 25c
Cortisone 
50 mg 5 20 ON 15 3î c
Cortisone 
100 mg 5 21 ON 15 39°
Normal : 
Untreated 2 __d 92
Cortisone 
50 mg 1 —  — —  — 96
Cortisone 
100 mg 2 ---- —  — 92





cortisone-treated groups. Peritoneal exudate cells obtained 
from the same cortisone-treated and untreated sensitive donors 
were significantly inhibited by PPD in vitro as compared with 
normal controls. A slight increase in the Mean Percent Mi­
gration was noted in the cortisone-treated sensitive animals 
as compared to untreated controls. The differences, however, 
were not statistically significant.
The effect of intramuscular cortisone treatment on 
the induction of delayed hypersensitivity in normal guinea 
pigs was also studied. The effect of cortisone treatment on 
the Mean Total Cell Yields and the Percent Mononuclear Cells 
of peritoneal exudates from each group are presented in 
Table 32. A depression in both the total cell yields and the 
percent mononuclear cells, as compared with untreated con­
trols, was noted in the groups treated with 500 mg of corti­
sone. The reduction in the number of mononuclear cells in­
cluded a decrease in both lymphocytes and macrophages. Peri­
toneal exudates from the other cortisone-treated groups were 
not effected either qualitatively or quantitatively. The ef­
fects of cortisone treatment on the induction of dermal reac­
tivity and in vitro cellular sensitivity to PPD are shown in 
Table 33» Although all animals developed progressively in­
creasing dermal sensitivity throughout the 3 week period, the 
skin reactivity but not MIF production of the animals treated 
with less than 500 mg of cortisone was depressed as compared 
to untreated controls. Central necrosis was displayed by
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TABLE 32









Untreated 5 0 . 1 3 99
Cortisone 
25 mg 5 0.12 95
Cortisone 
200 mg 5 0.10 98
Cortisone 
500 mg 5 O.O7& 7 2^
Normal:
Untreated 4- 0 . 1 5 99
Cortisone 
25 mg 2 0.12 97
Cortisone 
200 mg 2 0.14- 9 8
Cortisone 
500 mg 2 0 .0 9& i t
®-P=0.05.
TABLE 33
EFFECT OF INTRAMUSCULAR CORTISONE TREATMENT ON THE INDUCTION OF DELAYED 













Untreated 5 7 16 18 CN^ 20 CN 33
Cortisone 
25 mg 5 5 12 15 15 29
Cortisone 
200 mg 5 2 11 14 15 30
Cortisone 




25 mg 2 - — — — — — — 92
Cortisone 
200 mg 2 — —. — » tmm 94
Cortisone 









animals in the untreated control group at 2 and 3 weeks fol­
lowing sensitization. Central necrosis was not observed in 
any of the cortisone-treated animals. This critical observa­
tion is best interpreted as evidence that 25 and 200 mg of 
cortisone did not suppress induction of delayed hypersensi­
tivity. The group of animals treated with 500 mg cortisone 
displayed pronounced suppression of skin reactivity and MIF- 
mediated sensitivity. The skin reactions in these animals 
were not indurated and only erythematous areas were measur­
able. Histological sections of biopsied skin test sites from 
this group of animals revealed a significant depression in the 
mononuclear cell infiltration as compared to untreated sen­
sitive animals. Results of in vitro studies revealed that 
peritoneal cells from the group of animals treated with 500 mg 
cortisone were not inhibited significantly in vitro in the 
presence of 15 meg PPD as compared with untreated normal and 
sensitive controls. Although skin reactivity was depressed in 
the groups treated with 25 and 200 mg of cortisone, no sup­
pression of their peritoneal cell sensitivity in vitro was 
observed. In order to confirm these results, treatment with 
500 mg of cortisone over a 25 day period was repeated in a 
second group of animals. Results of this experiment confirmed 
the previous findings. Both skin reactivity and in vitro cel­
lular sensitivity were suppressed as compared to untreated 
controls (Table 3 )̂.
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TABLE 34
EFFECT OF LONG TERM CORTISONE TREATMENT ON THE INDUCTION OF DELAYED SKIN REACTIVITY AND IN VITRO SENSITIVITY TO TUBERCULIN
1 .......
11 Group No.Animals Mean Skin Reactivity7 14 21 Mean Percent Migration^
j Sensitive:
Untreated 5 l4 18 21 CN^ 40
Cortisone 
500 mg 5 12 12 16 EC 74^
Normal:
Untreated 2 —  — —  — —  — 90
Cortisone 
500 mg 2 -  - ---- —  — 89
^15 mcg/ml PPD.
^Central necrosis.
^Erythema without induration. 
dp=o.o5.
1 18
Thus, it would appear that low doses of cortisone 
suppress non-specific components of the inflammatory response 
associated with delayed hypersensitivity. Higher doses (500 
mg) suppress, in addition, the formation of cells capable of 
releasing MI F in response to specific antigenic challenge.
CHAPTER IV 
DISCUSSION
Methods for rendering guinea pigs sensitive to tuber­
culin are highly variable. Such factors as source, species, 
and strain of mycobacterial antigen; dose of immunogen and 
route of injection; and type and method of preparation of com­
plete Freund's adjuvant (CFA) appear to differ with each 
worker, according to reports in the literature. The lack of 
standardized procedures is due, in part, to the apparent ease 
with which the guinea pig can be sensitized to mycobacterial 
antigen, regardless of the method used. Leskowitz and Waksman 
(i960) reported, however, that the toe-pad and intradermal 
routes were most effective for production of delayed hyper­
sensitivity in rabbits to bovine serum albumin incorporated 
in CFA. The intramuscular, subcutaneous, and intraperitoneal 
routes were less effective and the intravenous route was 
totally ineffective. Various methods have been used for the 
sensitization of guinea pig donors of cells for in vitro 
macrophage migration studies. In the present study, subcu­
taneous injection of 5 mg of H37RV in FA was found to be as 
effective as sensitization by dual routes (subcutaneously and
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Intramuscularly) in rendering normal guinea pigs sensitive to 
PPD, as measured by the progressive development of dermal sen­
sitivity. The intramuscular route was less effective. It 
should be noted that the animals used in this study failed to 
display detectable signs of Arthus reactivity, as determined 
by the time required for the development of maximal skin re­
actions and by the examination of sections of biopsied skin 
test sites. However, since the two phenomena have been shown 
to be rather difficult to distinguish, when expressed simul­
taneously in the same animal, it is possible that both were 
present to some degree in these animals.
The effect of the dose of immunogen may be a critical 
factor in inducing the delayed type response. Salvin (1958) 
found that very small doses of protein antigen produced a 
transient state of pure delayed hypersensitivity, in the ab­
sence of detectable antibody, which persisted for only 2-3 
days. Hhr ad.. (1957) reported that pure delayed hypersen­
sitivity occurred 5-12 days after injection of normal guinea 
pigs with small amounts of antigen-antibody complexes pre­
cipitated in antibody excess and incorporated in CFA. Thus it 
would appear that guinea pigs injected with microgram amounts 
of protein antigen are more likely to develop a pure state of 
delayed hypersensitivity, while milligram amounts induce vig­
orous and protracted antibody formation (Cell and Benacerraf, 
1961). Raffel and Newell (1958) performed experiments using 
relatively high doses of protein antigen (0.5-1.0 mg
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ovalbumin) in an attempt to prove that the reactions seen in 
the earlier studies were different from classic delayed hyper­
sensitivity of the tuberculin type. The latter is known to be 
of long duration, while the former has been of a transient na­
ture in most studies. Leskowitz and Waksman (i960), however, 
using high immunizing doses of protein antigen (2.5 and 25 mg 
BSA) in rabbits, reported the production of both delayed hy­
persensitivity and humoral antibody to varying degrees. It 
should be noted that the use of high sensitizing doses of 
heat-killed mycobacterial cells has become customary, most 
probably due to the desire by most workers to induce high 
levels of delayed sensitivity in experimental animals, regard­
less of the simultaneous development of humoral antibody. The 
amount of undenatured tuberculoprotein remaining after heat- 
killing of mycobacterial cells raises a question ag to whether 
the actual quantity of immunogenic material injected is in 
excess, even when it is used in milligram amounts. Recent 
studies by Larson et ad. (1969) and Marcus (1970), however, 
indicated that microgram quantities of mycobacterial antigen 
were capable of producing delayed hypersensitivity to tuber- 
sensitivity to tuberculin in guinea pigs. Efforts in the 
present study to determine the effect of relatively high doses 
of heat-killed mycobacterial cells (0.5-10.0 mg) on the induc­
tion of tuberculin skin reactivity revealed that greater re­
activity was produced with the higher sensitizing doses (5«0 
or 10 mg) at 1 week after sensitization. However, no
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differences were detected in the reactivity of animals sensi­
tized with low and high doses at 2 and 3 weeks following sen­
sitization. These results suggested that the quantities of 
sensitizing antigen tested were all in excess of that required 
for sensitization.
Although a direct relationship between in vivo pas­
sive transfer of reactivity to tuberculin and the in vitro 
correlates of delayed hypersensitivity remains to be shown, 
it is apparent that they are all elicited by immunocompetent 
lymphoid cells. Chase (1965) emphasized the importance of the 
degree of sensitivity of donors of viable sensitive lymphoid 
cells, as well as the quantity of cells used, as prerequisite 
to successful passive transfer of delayed-type hypersensitiv­
ity in the guinea pig. In the present study, peritoneal cells 
from weakly sensitive donors failed to transfer tuberculin 
sensitivity in vivo, while those from highly sensitive animals 
did. Cell lysates prepared by sonic disruption of samples of 
the same cell suspension failed to confer dermal sensitivity 
to PPD to normal recipients. These results agree with those 
of Chase (1953)* It was assumed that the cells to be used in 
subsequent in vitro studies were also capable of transferring 
delayed-type hypersensitivity in vivo. It should be noted 
that the less sensitive donors in this experiment were sensi­
tized with 5 fflg of heat-killed mycobacteria (strain H3/Ra) 
while the highly sensitive animals were immunized with an
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equal quantity of H37Rv antigen which had been prepared by 
similar methods. These results confirm the variations in po­
tency of various antigen preparations.
The transient, non-specific skin reactions observed 
following PPD skin testing of normal recipients in passive 
transfer experiments in vivo were found to be due to the com­
mercial phosphate buffer diluent rather than the tuberculin 
itself. Substitution of pyrogen-free saline for the commer­
cial buffer as a diluent eliminated this problem. These reac­
tions may have been a result of the unique sensitivity of the 
guinea pig skin to some component of the commercial diluent, 
since there appear to be no reports of similar non-specific 
reactions in humans skin tested with the same materials. It 
should be noted that David (I96^a) prescribed the use
of a pyrogen-free saline to dilute PPD for skin testing guinea 
pigs. The non-specific reactions noted in the present study 
were predominantly erythematous, with little induration. 
Stetson (1959) noted that the skin reaction resulting from the 
intradermal injection of bacterial endotoxin was very similar 
to the tuberculin reaction in timing and in gross and histo­
logical appearance. Although the non-specific erythema seen 
in the present study did not mimic the tuberculin reaction, 
it seems possible that minute quantities of endotoxin contam­
inants could elicit such a response. A more probable cause 
for the non-specific skin reactions might have been the
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presence of preservatives (0.5^ phenol) in the commercial di­
luent. This possibility arose again later when PPD contain­
ing preservatives was found to be highly toxic for normal 
guinea pig peritoneal cells in vitro.
The in vitro model introduced by George and Vaughan 
(1962) for studying delayed hypersensitivity prescribed the 
use of Mackaness-type incubation chambers for the capillary 
tube migration system. It seemed desirable to evaluate the 
possibility of utilizing an incubation chamber which would be 
less complicated and expensive than the Mackaness chamber.
For this purpose, a short-style Leighton type tissue culture 
tube was evaluated (Leu and Patnode 1968). This modification 
was adapted successfully to the in vitro system and seemed to 
offer definite advantages in ease of handling, ready avail­
ability, and economy.
Preliminary studies designed to evaluate various as­
pects of the m  vitro capillary tube method revealed that the 
optimal time for recording the inhibition of macrophage migra­
tion was 18-2^ hr at 37 C. Essentially no changes in migra­
tion occurred after 2k hr incubation. David (1968), using 
Mackaness-type chambers, reported that inhibition of migration 
from capillary tubes could be observed in a few hours, al­
though the tests were read after l8-2^ hr. It appears that 
MIF-mediated sensitivity is fully expressed within the 18 hr 
period of incubation, regardless of the chamber used.
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Most workers have used relatively high concentrations 
of PPD (15-50 mcg/ml) for detection of in vitro sensitivity of 
peritoneal cells. David ^  a2. (I96^a) reported that, occa­
sionally, cells from normal animals were inhibited in the 
presence of 15 or 30 mcg/ml concentrations of PPD. In the 
present investigation 15, 20, and 30 mcg/ml concentrations of 
a commercial PPD preparation were found to be inhibitory and 
cytotoxic for normal guinea pig peritoneal macrophages. 
Sensitive cells were inhibited to a greater extent than normal 
cells with the same concentrations of PPD. However, an end­
point titration method was devised to determine the concen­
tration of PPD which would inhibit migration of sensitive 
cells with minimal inhibition of normal cells. It was found, 
in an initial experiment, that as little as 0.5 mcg/ml of PPD 
inhibited cells from highly sensitive animals. However, this 
concentration did not inhibit cells from less sensitive ani­
mals. Therefore, 5 mcg/ml was chosen as the endpoint concen­
tration. The cytotoxicity of the commercial PPD was appar­
ently due to the presence of purified cresols (0.06 mg/U-0 meg 
PPD tablet) in the commercial preparation, since in subse­
quent experiments a batch of PPD which contained no preserva­
tives was found to be non-toxic for normal cells. Waksman 
and Matoltsy (1958) reported that antigens containing germi­
cides as preservatives were non-specifically toxic for peri­
toneal cell cultures in vitro. Heilman e_t a l . (i960) ob­
served similar cytotoxic effects of antigens containing
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preservatives. Bloom and Bennett (1966) described the use of 
PPD, free of additives, for in vitro macrophage migration 
studies.
David (1968) reported that the degree of macrophage 
migration inhibition was related to the dose of antigen in the 
incubation chambers. He demonstrated a dose response curve in 
which increasing concentrations of bovine gamma globulin anti­
gen (BGG) resulted in increasing inhibition of macrophages 
from BGG-sensitive animals. Results of a similar experiment 
in the present study indicated that essentially no dose re­
sponse was demonstrable with increasing concentrations of PPD 
(without preservatives). No major differences were noted in 
the degree of inhibition of cells from highly sensitive ani­
mals in the presence of 1.0-20 mcg/ml of PPD. Similarly, 
Ferraresi et (1969) were unable to demonstrate an in vitro 
dose response in guinea pigs sensitized to diphtheria toxoid 
except in animals with moderate skin reactivity.
These results suggested that the antigen concentra­
tions used in the present in vitro studies were in excess and 
that a dose response may be demonstrable with lower concentra­
tions of PPD. It became evident from these results that the 
response to increasing doses of PPD containing preservatives, 
observed in previous experiments, was due to the non-specific 
cytotoxic effects of the preservatives rather than the spe­
cific inhibition by antigen. In a subsequent experiment,
5 mcg/ml of PPD containing preservatives was found to be no
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more toxic for normal macrophages than was 15 mcg/ml of PPD 
without preservatives. Moreover, inhibition of migration of 
sensitive cells in the presence of these two antigen prepara­
tions was found to be nearly identical. It was concluded that 
the 5 mcg/ml concentration of PPD containing preservatives was 
equivalent to 5-20 mcg/ml concentrations of the PPD prepara­
tion free of preservative.
David et (I96^a) suggested that in vitro inhibi­
tion of migration of peritoneal macrophages from tuberculin- 
sensitive guinea pigs could not be directly correlated with 
the diameter of the skin reaction in the same animal, although 
there was, in general, a close parallelism. In the present 
study, there was a statistically significant correlation be­
tween the diameters of the tuberculin skin reactions and the 
degree of inhibition of peritoneal macrophage migration in 
vitro. In a few cases, cells from animals with pronounced 
skin reactivity were not as markedly inhibited as were cells 
from animals with equally high skin sensitivity. Contrary to 
the findings of David et (1965a), however, there were no 
instances in which cells from animals with minimal skin reac­
tivity were markedly inhibited in vitro. It should be noted 
that these workers utilized guinea pigs that had been sensi­
tized 2-9 months prior to testing, whereas the animals used 
in the present study had been sensitized only 3-6 weeks pre­
viously. Another possible explanation for the disparity in 
results could be the difference in concentrations of PPD used
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for skin testing and in vi tro assays. David e t (196U-a) 
used 10 meg of PPD for skin testing and 15 mcg/ml of PPD for 
in vitro tests, while in the present study 5 meg of PPD was 
used for both in vivo and in vitro testing. It seems possible 
that a higher degree of correlation between skin reactivity 
and in vitro sensitivity may exist only during the earlier 
stages of immunization. Ferraresi et (1969) noted less 
correlation between delayed-type skin reactivity and in vitro 
sensitivity when sensitivity was declining (i.e., 3-'+ months 
after sensitization) than earlier in the sensitization proc­
ess. The use of the same concentration of PPD for both in 
vivo and in vitro testing may also increase the possibility 
of detecting equivalent levels of sensitivity.
Although there is strong presumptive evidence that 
MIF-mediated in vitro sensitivity is an expression of delayed 
hypersensitivity, no attempts had been made to correlate 
quantitatively the induction and expression of dermal reac­
tivity and in vitro MIF-mediated sensitivity to PPD. Results 
of.preliminary studies suggested that detectable skin reac­
tivity preceded in vitro cellular sensitivity to PPD (Leu and 
Patnode, 1968). Significant inhibition of cell migration was 
not detected until skin reactivity became maximal (3-5 weeks 
post-sensitization). Histological studies of biopsied skin 
test sites from these animals revealed that the reactions 
were characteristic of delayed-type hypersensitivity. How­
ever, it seemed possible that low levels of MIF-mediated
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sensitivity were not detected early in the sensitization proc­
ess due to the inability to use higher concentrations of PPD 
(containing cytotoxic preservatives) for in vitro assays. In 
subsequent studies, using higher concentrations of a non­
toxic PPD preparation, significant inhibition of migration 
was detected with peritoneal cells from some individual sensi­
tive animals as early as 1-2 weeks after sensitization. As 
was found in the initial experiments, however, significant 
cellular sensitivity to PPD was detected in most animals only 
when pronounced skin reactivity was evident in a parallel 
group of animals reserved for skin testing. Other workers 
have reported similar results. Ricci ^  al. (1969) noted that 
in vitro cellular sensitivity to PPD in most animals was sig­
nificant only at 3 weeks post-sensitization, concurrent with 
the appearance of intense tuberculin skin reactivity. In a 
similar study, Ferraresi et al. (l 96^ confirmed that skin re­
activity developed earlier and more rapidly than did in vitro 
sensitivity. They also noted that, once sensitivity was well 
established in guinea pigs sensitized with diphtheria toxoid 
or human gamma globulin in CFA, in vivo and in vitro reactiv­
ities became more closely correlated quantitatively than 
early in the induction phase of sensitization.
It seemed possible that an excess dose of sensitizing 
antigen could preferentially block the development of in 
vitro cellular sensitivity by some mechanism similar to im­
mune tolerance. Based on this premise one would have to
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presume that subtle differences exist between the basic mech­
anisms involved in skin reactivity and in vitro sensitivity.
In further studies, however, no significant differences were 
detected in the time of development of in vitro cellular sen­
sitivity in animals sensitized with 0.5? 5-0, or 10 mg 
antigen. Based on a recent report by Marcus (1970), it be­
came evident that the dose of sensitizing antigen may play an 
important role in the early induction of MIF-mediated sensi­
tivity simultaneously with tuberculin skin reactivity. In 
carefully controlled studies, it was demonstrated that inbred 
guinea pigs sensitized by multiple intradermal injections of 
minimal doses (total of 12.5 or 25 meg) of dead mycobacteria 
developed concurrent skin reactivity and in vitro sensitivity 
as early as 6-7 days following sensitization. The methods of 
sensitization employed appeared to be similar to those used 
to induce Jones-Mote type sensitivity (Crowle 1962). However, 
since the sensitivity was not transient, it is probable that a 
state of classical delayed hypersensitivity was established. 
The use of inbred strains of guinea pigs may also have been a 
contributing factor to the early and uniform development of 
in vitro sensitivity. In other studies, including the present 
work, outbred strains of guinea pigs were used. All workers 
have reported occasional, early detection of in vitro sensi­
tivity in individual animals within a sensitized group. 
Therefore, it appears possible, that early uniform expression 
of both in vivo and in vitro sensitivity might be enhanced by
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the use of Inbred strains of animals selected for their high 
susceptibility to sensitization. The reason for the delay in 
the expression of in vitro sensitivity in studies performed 
using excess sensitizing antigen remains to be seen. One pos­
sible explanation is that there may be an uneven distribution 
of immunocompetent lymphoid cells during the early stages of 
sensitization. For example, more immunocompetent lymphocytes 
may be available from the peripheral blood for eliciting skin 
reactivity (Kosunen et al., 1963) than from the local lymph 
nodes, which have been shown to be the primary source of small 
lymphocytes in guinea pig peritoneal exudates (Turk and Polak, 
1967). This concept is supported by the in vitro studies of 
Carpenter (1963) who reported that macrophage sensitivity 
could be detected in explants of tuberculin-sensitive guinea 
pig lung and focal lymph nodes (adjacent to sites of injection 
of immunizing antigen), 5 days after sensitization, when de­
layed skin reactions were first demonstrable. However, mac­
rophages from explants of distant lymph nodes and spleen were 
not inhibited until 2-4- weeks after immunization.
Since the alveolar macrophage is the predominant leu­
kocyte type found in the alveolar spaces of the lung, it may 
be the primary line of defense against pulmonary infections 
with the tubercle bacillus in man. Tsuji et aH. (1964) re­
ported successful passive transfer of tuberculin sensitivity 
in rabbits using either viable cells or cell lysates of
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alveolar macrophages. Dunn (1966) reported similar positive 
findings in local passive transfer experiments when alveolar 
macrophages from tuberculin-sensitive guinea pigs were mixed 
with antigen prior to intradermal injection into normal re­
cipients. The methods of Myrvik et a l . (1961) and Maxwell et 
al. (196'+) were utilized to collect guinea pig alveolar mac­
rophages in this study. These workers had reported yields of 
almost pure alveolar macrophages which contained virtually no 
lymphocytes, in the rabbit and guinea pig, respectively. 
Similar cell yields were obtained from the guinea pig lung 
using these methods in the present study. Preliminary studies 
revealed that alveolar macrophages obtained from tuberculin- 
sensitive guinea pigs, which displayed pronounced skin sensi­
tivity and iju vitro peritoneal exudate cell sensitivity to 
PPD, were not inhibited in vitro. It was concluded from mi­
croscopic observations of stained smears that the inability 
to demonstrate MIF-mediated sensitivity was due to the virtual 
absence;- of immunocompetent lymphocytes in alveolar cell sus­
pensions (Bloom and Bennett, 1966). Subsequent attempts to 
induce MIF-mediated sensitivity in vivo by using various meth­
ods of sensitization were largely unsuccessful. Heise ejt al. 
(1968) demonstrated in vitro sensitivity of alveolar macro­
phages from BCG-sensitive guinea pigs. The macrophage inhi­
bition was clearly demonstrated to be mediated by a cyto- 
philic antibody (probably IgG of Y-2 type) and not by MIF. 
Bartfeld ^  al. (1969) reported that they had demonstrated in
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vitro sensitivity of alveolar cells obtained from guinea pigs 
sensitized with CFA. They reported that their guinea pig lung 
washings contained 20% lymphocytes. However, in further 
studies (Bartfeld and Atoynaton, 1969) it was found that the 
inhibiting activity was due to a cytophilic factor other than 
MIF. In the present work, attempts to induce alveolar cell 
sensitivity by the methods of Heise ejt al. (1968) failed to 
produce convincing results. Only slight inhibition of alveo­
lar macrophage migration was detected in vitro, while pro­
nounced dermal and peritoneal cell sensitivity was demon­
strable in the same donor animals. It should be noted that, 
although the same procedures were used, H37Hv antigen was used 
instead of BCG as the sensitizing antigen in this study. It 
seems possible that subtle differences in antigen prepara­
tions might account for the disparity in these results. The 
number and variability of potential immunogenic components of 
these different strains of mycobacteria has been demonstrated 
by Parlett and Youmans (1956)-
Cohn and Weiner (1963) noted that the intravenous in­
jection of rabbits with BCG suspended in Tween 80 resulted in 
infiltration of mononuclear cells into the alveolar spaces of 
the lung. In the present work, similar attempts to sensitize 
animals by the intravenous, intracardial, and intrapleural 
routes, were made with the hope of inducing the infiltration 
of immunocompetent lymphocytes into the lung tissue. Results 
of these experiments were surprising since MIF-mediated
13^
alveolar cell sensitivity was not demonstrated in most of 
these animals in spite of pronounced granulomatous responses 
in their lung tissue. Even in the presence of gross path­
ology, lung washings from these animals contained virtually 
no lymphocytes. It was concluded that the fihrotic tissue 
response to mycobacterial antigen had effectively walled off 
the effected areas, so that only cells in the alveolar spaces 
from the remaining healthy areas of the lung were collected 
by the washing procedures used. Low levels of in vitro sensi- 
•tivity were detected in the animals injected intracardially 
with mycobacterial antigen. Differential counts revealed 
only 5-10^ lymphocytes in alveolar cell suspensions from 
these animals. The degree of alveolar macrophage inhibition 
was similar to that obtained with animals sensitized by the 
method of Heise et al. (1968). Carpenter (1963) observed in 
vitro inhibition of macrophage migration from lung explants 
of tuberculin-sensitive guinea pigs. Since explants of lung 
tissue contain both lymphocytes and macrophages, it would ap­
pear that these results emphasized the necessity for the 
presence of immunocompetent lymphoid cells to elicit MIF- 
mediated alveolar macrophage inhibition. In studies utiliz­
ing chromosome markers to trace their migration, Pinkett et 
al. (1966) reported that most alveolar macrophages are of bone 
marrow (mesodermal) origin. Recently, Bowden et al. (1969), 
utilizing cells labelled with ^H-thymidine in radiation 
chimeras, reported that the progeny of a stem cell in the
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bone marrow was transported via the blood to the lung inter- 
stitinm where it undergoes a division-maturation. Differen­
tiation of the stem cells into mature alveolar macrophages 
occurs in the alveoli. It would appear from these results 
that the alveolar macrophage is not thymus dependent 
(Williams and Waksman, 1969)*
Attempts to demonstrate MIF-mediated alveolar cell 
sensitivity by mixing sensitive and normal cell suspensions in 
various proportions prior to in vitro assay revealed that the 
alveolar macrophage was less susceptible to antigen specific 
inhibition by this method than was the peritoneal macrophage. 
Mixtures of sensitive and normal peritoneal cells were mark­
edly inhibited in the presence of PPD. Generally, the degree 
of inhibition increased with higher concentrations of sensi­
tive cells in the cell mixtures. Furthermore, the degree of 
sensitivity conferred on normal peritoneal cells appeared to 
be more pronounced when they were mixed with cells from highly 
sensitive donors. However, when alveolar and peritoneal cell 
mixtures from the same sensitive donors were tested for their 
in vitro sensitivity to PPD, no significant macrophage inhi­
bition was detected, with one exception. In this instance 
only minimal inhibition was observed. In a subsequent study 
it was found that mixtures of sensitive and normal peritoneal 
cells were inhibited to a greater extent by PPD in vitro than 
were corresponding mixtures of the same sensitive peritoneal 
cells and alveolar cells from the same donors. Only when a
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purified, sensitive lymphocyte suspension (separated from 
peritoneal exudates) was mixed with equal numbers of alveolar 
macrophages was pronounced inhibition of migration detected.
It was apparent from these studies that the alveolar macro­
phage was less susceptible to the effects of MIF-mediated 
sensitivity in vitro than its peritoneal counterpart. Pollock 
et al. (1970) reported that inhibition of migration was more 
difficult to demonstrate with alveolar cells than with peri­
toneal cells when they were mixed with sensitive lymphocytes. 
They attributed this difference to the fact that alveolar 
macrophages migrated to a greater extent than did peritoneal 
macrophages. Gesner and Howard (196?) have pointed out dis­
tinct biochemical differences between these two macrophage 
types in that the alveolar macrophage utilizes both oxidative 
phosphorylation and aerobic metabolism as an energy source, 
while the peritoneal macrophage depends solely on anaerobic 
glycolysis as a source of energy. The alveolar cell is gen­
erally more active metabolically in producing much higher 
levels of lysosomal enzymes than is the peritoneal cell.
Based on these observations, it seems possible that the dif­
ficulties encountered, in the present study, in demonstrating 
pronounced in vitro cellular sensitivity of the alveolar 
macrophage might be due to the inherent metabolic properties 
of this cell type. If MIF acts as a non-specific pharmaco­
logic effector molecule in inhibiting the macrophage (Dumonde 
et al., 1969), it is possible that the unique metabolic
137
properties of the alveolar macrophage make it less susceptible 
to this type of mechanism. Alternatively, if macrophage in­
hibition is dependent on an antigen specific MIF effector 
molecule which is cytophilic for the macrophage (Amos and 
Lachman, 1970)5 the disparity in the expression of inhibition 
of alveolar and peritoneal macrophages could be due to differ­
ences in the nature of receptor sites on their cell surfaces.
It has been reported that immune serum may either en­
hance the in vitro sensitivity of sensitive cells (Carpenter, 
196 3) or passively sensitize normal cells to PPD (Bloom and 
Bennett, 1966 and Heise ^  al. 1968). In the present study, 
immune serum was found to have no effect on normal or sensi­
tive peritoneal macrophage inhibition. However, in subsequent 
studies pooled serum from tuberculin-sensitive animals was 
found to markedly enhance the in vitro sensitivity of alveolar 
cells obtained from animals sensitized by the intradermal or 
subcutaneous routes. No similar enhancing effect was ob­
served with alveolar cells from normal animals. Furthermore, 
no effect was seen with alveolar cells obtained from sensitive 
animals when the cells were incubated with immune serum col­
lected at 1 and 2 weeks post-sensitization,- while serum col­
lected at 3 weeks after sensitization induced significant 
inhibition of migration. It appears that the sensitive alve­
olar cells may have had a low level of immunologic potential 
which was undetected in vitro until it was enhanced by the 
addition of the serum factor. Since the degree of alveolar
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cell inhibition seen in the presence of immune serum was pro­
nounced, as compared to the moderate lymphocyte-mediated in­
hibition observed in previous experiments, it seems possible 
that this inhibition was due to a cytophilic antibody similar 
to that described by Heise et , 1968. In addition, only 
alveolar cells, and not peritoneal cells, from sensitive ani­
mals were effected by the serum factor.
The effect of cortisone on in vivo and in vitro sen­
sitivity was examined in the present studies. Intraperi-- 
toneal injection of 100 mg (but not 25 or 50 mg) of cortisone 
acetate was found to partially suppress MIF-mediated sensi­
tivity of peritoneal exudate cells. Johnson and Sherago.
(1964) reported partial suppression of in vitro sensitivity 
to PPD of peripheral blood leukocytes from guinea pigs in­
jected with 25 mg cortisone by the intraperitoneal route.
They also noted a concomitant lymphopenia. In the present 
study, no reduction in the number of mononuclear cells in 
peritoneal exudates was observed, although the total cell
yields were reduced as compared to control animals.
Leahy and Morgan (1952) reported that prolopged 
cortisone treatment (100 mcg/ml) protected sensitive spleen 
explant macrophages from the cytotoxic effects of PPD in 
vitro. In the present study, short term incubation of normal 
or sensitive peritoneal cells with 100 or 200 meg cortisone/ml 
prior to in vitro assay resulted in stimulation of macrophage 
migration in the absence of PPD. Samples of the same
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cortisone-treated cells were inhibited in the presence of 
antigen and therefore no significant effect on in vitro sensi­
tivity to PPD was demonstrated. Leahy and Morgan (1952) and 
Heilman (1969) reported that low concentrations of cortisone 
stimulated in vitro macrophage migration from spleen ex­
piants. In the present study, a subsequent experiment re­
vealed that sensitive cells which had been preincubated with 
100 meg cortisone/ml, followed by continued in vitro treat­
ment with the same concentration of cortisone incorporated 
into the tissue culture medium, were significantly suppressed 
in their MIF-mediated sensitivity to PPD as compared to un­
treated sensitive and normal control cells. Similar treat­
ment of sensitive cells with 200 meg cortisone/ml was found 
to be cytotoxic. These results suggest that prolonged incu­
bation of sensitive cells with relatively high concentrations 
of cortisone acetate may suppress MIF-mediated sensitivity. 
However, the specific mechanism by which cortisone blocks the 
macrophage inhibition phenomenon remains to be determined. 
Based on the report of Hinz ^  (1970), lymphocyte trans­
formation was suppressed in a patient on high doses of 
prednisone as a therapeutic regimen. Cortisone also has been 
shown to stimulate macrophage migration and protect against 
the cytotoxic effects of endotoxin (Heilman, 1969), pre­
sumably due to stabilization of lysosomal and perhaps other 
cell membranes (Weissman and Thomas, 1962). Therefore the 
suppression by cortisone of MIF-mediated sensitivity vitro
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may be due to effects on both the lymphocyte and the macro­
phage.
Most Immunosuppressive agents are effective only when 
they are administered prior to the administration of immuno­
gen (preinductive phase) or during the sensitization process 
(Inductive phase). Generally, these agents are ineffective 
once the immune response is established (Gabrielsen and Good, 
1967). In the present work, intramuscular administration of 
cortisone acetate to previously sensitized guinea pigs de­
pressed tuberculin skin reactivity, total cell yields, and the 
percent mononuclear cells in peritoneal exudates, but failed 
to suppress in vitro sensitivity to PPD. These results do 
not negate the possibility that long term administration of 
cortisone to fully sensitive animals would result in immuno­
suppression. The relative ease with which parenteral admin­
istration of immunosuppressive agents suppresses delayed-type 
skin reactivity is well documented (Gabrielsen and Good,
1967, Gowans and McGregor, 1965). However, the possibility 
exists that this type of suppression is due only to the anti­
phlogistic and anti-inflammatory effects of these agents 
rather than their specific suppression of immunocompetency.
The results of the present study support this concept. Based 
on the previous observation, prolonged incubation of sensi­
tive cells in vitro with high concentrations of cortisone was 
required to block MIF-mediated sensitivity. Therefore, it 
seems logical to assume that prolonged administration of high.
1̂ 1
doses of cortisone would be required to suppress immunocom­
petency in fully sensitive animals.
Studies on the effect of cortisone on the induction 
of tuberculin sensitivity revealed that only animals that had 
been treated continuously with high dosages (500 mg total) of 
cortisone, beginning prior to sensitization and continuing 
through the period of induction (i.e., approximately 3 weeks), 
were suppressed in both dermal reactivity and MIF-mediated 
sensitivity in vitro. Animals that were treated in the same 
manner with lower doses of cortisone (200 mg total) displayed 
depression of skin reactivity without suppression of in vitro 
cellular sensitivity. There have been numerous reports in 
the literature of failure to suppress in vitro sensitivity in 
the presence of depressed dermal reactivity following the ad­
ministration of therapeutic doses of immunosuppressive agents. 
Cummings and Hudgins (1952) failed to block passive transfer 
of tuberculin hypersensitivity in the guinea pig by prolonged 
treatment (21 days) of sensitive donors with low doses (^2 mg 
total) of cortisone acetate beginning at the time of sensi­
tization. Depression of tuberculin skin reactivity was pro­
nounced in the sensitive peritoneal cell donors. Lurie e_t ad. 
(19^9) reported that treatment of tuberculin-sensitive rabbits 
with estrogen suppressed dermal but not cellular sensitivity. 
Axelrod et ad. (1963) noted that although pyridoxine defi­
ciency depressed tuberculin skin sensitivity, both in the 
inductive and productive phases of BCG-sensitization in guinea
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pigs, the ability of their peritoneal cells to transfer sen­
sitivity passively was not compromised. Recently, Phillips 
and Zweiman (1970) reported that treatment of tuberculin-sen­
sitive guinea pigs with 6-mercaptopurine suppressed skin re­
activity to PPD, but had no effect on MIF-mediated sensitiv­
ity. These observations are in agreement with the present 
results and appear to support the concept that many immune-' 
suppressives may act primarily as anti-inflammatory agents.
It is interesting to note that immunosuppressive agents which 
are lympholytic or antimetabolites have been reported to be 
effective in suppressing delayed-type immune competency.
For example, Cummings et al. (1955) noted that total body x- 
irradiation diminished tuberculin skin reactions and impaired 
the ability of sensitive leukocytes to transfer sensitivity 
passively. Bloom ^  aR. (1964) reported that treatment of 
guinea pig peritoneal leukocytes in vitro with mitomycin C 
blocked their ability to transfer tuberculin skin reactivity 
to normal recipients. Results of the present study suggest 
that cortisone acetate may be relatively less potent in sup­
pressing specific delayed-type immunecompetency than it is in 
depressing the non-specific inflammatory response.
CHAPTER V 
SUMMARY
For in vitro studies of delayed hypersensitivity uti­
lizing the inhibition of macrophage migration technique, the 
method of George and Vaughan was successfully modified by the 
adaptation of a short-style, Leighton-type tissue culture 
tube as an incubation chamber. This modification resulted in 
typical and reproducible cell migration and appeared to offer 
the advantages of simplicity, ease in handling, ready avail­
ability, and economy.
Experiments designed to determine the optimal route 
of sensitization of guinea pigs to tuberculin, through the use 
of heat-killed tubercule bacilli in Freund's incomplete ad­
juvant, revealed no significant differences between animals 
dually sensitized by the subcutaneous and intramuscular 
routes and those sensitized by either route alone. The dose 
of mycobacterial antigen used appeared to have no affect on 
the development of maximal tuberculin skin reactivity. In 
vivo passive transfer of sensitivity to tuberculin was ac­
complished with viable, but not sonic-disrupted, peritoneal 
cells from donors sensitized by the subcutaneous route.
1̂ 3
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Transient skin reactivity observed following injection of nor­
mal recipient animals with commercial PPD preparations was 
found to be due to a non-specific irritant in the commercial 
diluent. Substitution of pyrogen-free saline as a diluent 
eliminated this problem.
Commercial PPD preparations were also found to be cy­
totoxic for guinea pig peritoneal cells in vitro due to the 
presence of cresol preservatives. An endpoint titration 
method was devised for determining an effective, non-toxic 
concentration of PPD which would be suitable for in vitro 
macrophage migration studies. Subsequent in vitro studies, 
utilizing a PPD préparation without preservatives, eliminated 
the problem of non-specific macrophage inhibition.
Quantitative studies, designed to compare the time re­
quired for induction of in vivo and in vitro tuberculin hyper­
sensitivity, revealed that the development of dermal sensi­
tivity preceded detectable in vitro cellular sensitivity to 
PPD. Further studies showed that a few individual animals 
displayed low levels of early, in vitro sensitivity concomi­
tantly with the development of skin reactivity. However, in 
most animals MIF-mediated sensitivity followed the develop­
ment of skin reactivity and generally was demonstrable only 
at a time when the dermal response was maximal. No signif­
icant differences were seen in the induction of in vivo and 
in vitro sensitivity in animals sensitized with doses of my­
cobacterial antigen ranging from 0.5 mg to 10 mg.
i>+5
Alveolar macrophages obtained from tuberculin skin 
_t.est positive guinea pigs were not inhibited by PPD in vitro,' 
even though peritoneal cells from the same donors were in­
hibited. Lack of alveolar cell sensitivity was attributed to 
the absence of immunocompetent lymphocytes which have been 
shown to be necessary for the production of Migration Inhi­
bitory Factor (MIF). Attempts to induce alveolar cell sensi­
tivity by intravenous, intracardial, intradermal, and intra­
pleural injection of mycobacterial antigen were generally un­
successful. Intravenous challenge of sensitive animals with 
PPD also failed to confer sensitivity to alveolar macrophages 
passively in vivo. Sensitive peritoneal cells were shown to 
confer pronounced in vitro sensitivity on normal peritoneal 
cell populations. However, when similar mixtures of sensi­
tive peritoneal and normal alveolar cells were tested, only 
slight inhibition of migration was detected. Only when puri­
fied lymphocytes, separated from sensitive peritoneal exu­
dates, were mixed with alveolar cells was pronounced macro­
phage inhibition demonstrable.
The effect of immune serum on in vitro migration of 
normal and sensitive peritoneal and alveolar cells was also 
studied. Immune serum had no effect on the in vitro sensi­
tivity of normal or sensitive peritoneal exudates or normal 
alveolar macrophages. However, alveolar macrophages from 
tuberculin-sensitive donors were significantly inhibited by 
PPD in vitro in the presence of pooled immune serum. The
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serum factor was shown to be present in serum collected from 
animals at 3 weeks, but not at 1 or 2 weeks post­
sensitization.
Partial suppression of in vitro sensitivity was seen 
in tuberculin-sensitive guinea pigs injected intraperitoneally 
with 100 mg' cortisone acetate 24 hr prior to collection of 
peritoneal exudates. Preliminary studies on the effect of 
cortisone treatment of sensitive peritoneal cells in vitro 
revealed that continuous treatment with 100 meg cortisone/ml 
effectively blocked MIF-mediated sensitivity to PPD.
Studies were performed to determine the effect of 
intramuscular cortisone administration on the induction and 
expression of tuberculin sensitivity in the guinea pig. The 
results revealed that partial suppression of dermal reactivity 
following short term intramuscular administration of high 
doses of cortisone may be due largely to a non-specific anti­
inflammatory effect. It would appear that marked suppression 
of delayed hypersensitivity in the guinea pig, as measured by 
pronounced depression of skin reactivity, decreased numbers 
of mononuclear cells, and suppression of MIF-mediated in vitro 
sensitivity is attainable only by continuous, long term ad­
ministration of high doses of cortisone. Short term treat­
ment with cortisone, even during the induction phase of sen­
sitization, produces, at most, only transient suppression of 
cellular sensitivity. These results do not negate the possi­
bility that similar long term cortisone treatment of fully 
sensitive animals would result in marked immunosuppression.
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